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Abstract 
Bovine reproductive performance is one of the most important factors 
influencing dairy farm profitability. Present-day techniques for oestrus- and 
pregnancy-detection are unreliable and labour-intensive. Although measuring 
milk-progesterone at regular intervals allows the fertility status of a cow to be 
determined reliably, the labour cost of collecting and analysing samples is 
prohibitive. 
This project aimed to develop a progesterone sensing system that could be 
automated and integrated with the milking unit, thus minimising labour costs. 
The proposed system involved mixing the milk sample with an enzyme-
antibody conjugate and then passing the sample through a column containing 
immobilised progesterone. Any progesterone in the milk would inhibit 
conjugate binding to the column. An enzyme substrate would then flow 
through the column and bound conjugate would be detected as a colour 
change at the column’s outlet. 
Periodate-coupling was used to attach horseradish peroxidase enzyme to anti-
progesterone antibody, and progesterone-3-carboxymethyloxime was 
immobilised on the polystyrene bead surface using amine-coupling. Both 
techniques are widely used. Initial experiments attempted to verify the success 
of these two reactions simultaneously, whereas later experiments focused on 
the bead-coating. Beads were suspended in a specially-constructed syringe and 
the antibody activity of the eluted solution was measured by SPR. However, a 
combination of non-specific binding and antibody stability and activity issues 
meant neither reaction was conclusively verified. Many trials were done to 
investigate how to overcome the problems encountered but a suitable, 
workable procedure was not developed. 
Despite poor progress, the problems encountered did not undermine the 
project’s potential. There remains optimism of developing an on-line method if 
research were to continue. 
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Chapter 1 Background 
The dairy industry is New Zealand’s primary exporter, producing over 40% of 
our total export earnings. Nearly all dairy farms operate under a pasture-fed 
regime, with supplementation from hay or silage when grass growth is low. 
Milk is collected at a central milking parlour, normally twice daily (although 
some farms collect only once daily). Towards the end of lactation, collection 
may decrease to once daily. 
In New Zealand, cows normally calve in July, August or September and 
commence lactation at this time. This calving time is optimal so that maximum 
milk production will coincide with the spring peak in grass growth. After this 
peak, the cows’ milk production gradually decreases until they are dried-off in 
April or May, depending on grass growth. The annual milking cycle is not 
unique to New Zealand. Dairy systems worldwide are normally based on an 
annual reproductive cycle and therefore depend on successful mating at a 
specific time of the year - spring in New Zealand. 
The New Zealand industry uses a combination of artificial insemination and 
natural mating to breed cows. Since 1909, herd testing, measuring the yield 
(litres) and solids content of milk from every cow in the herd, has been used to 
identify high performing cows, whose progeny are likely to be valuable. 
Artificial insemination allows farmers to obtain the genes of the highest 
quality sires without owning the animal. However, for successful conception, 
it is crucial that insemination occurs at the correct time in the oestrous cycle. 
Pregnancy then needs to be confirmed so that re-insemination can occur if 
required. 
Herd reproductive performance is one of the most important factors 
influencing dairy farm profitability. Cows that conceive late, calve late, and 
therefore begin to milk late, and may spend less time in milk. Every day a cow 
remains empty costs the farmer money. Although a cow may have high milk-
producing capability, she may be culled if she fails to conceive. 
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Despite the importance of reproductive performance to dairy farming 
profitability, there are relatively few tools available and in wide use for the 
farmer to manage fertility. Oestrus detection typically involves observing 
animal behaviour. In some herds oestrus is synchronised across the entire herd 
by the use of hormone-impregnated controlled-release vaginal implants. 
Pregnancy is typically detected by rectal palpation by a trained technician. 
Milk progesterone measurement has long been thought to have potential as a 
fertility management tool. Progesterone concentration is very low at oestrus 
and slightly above normal levels throughout pregnancy, so it can be used for 
oestrus detection and cautiously for pregnancy confirmation. Although several 
different technologies have been investigated, no on-line progesterone 
biosensor is available. Therefore, samples need to be collected from all cows 
every three or four days and analysed quickly before the insemination-window 
passes. This system is not very practical so attempts to implement lab-based 
milk progesterone schemes have failed. 
The aim of this thesis was to develop an on-line biosensing platform for 
progesterone, based on a flow-through enzyme-linked immunosorbent assay 
using a solid phase column of beads coated with immobilised progesterone. 
The milk sample would be mixed with an enzyme-antibody conjugate and 
then flow through the column. Any progesterone in the milk would inhibit 
conjugate from binding to the immobilised progesterone on the beads. An 
enzyme substrate would then flow through the column and the bound 
conjugate would be detected as a colour change at the outlet of the column. A 
large colour change indicates a large amount of bound conjugate and therefore 
a low milk progesterone concentration. The key requirements are that the 
biosensor is simple and robust, and has low running costs and relatively low 
capital costs. The milking environment is very different from the lab 
environment and the sensor needs to be designed accordingly. 
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Chapter Two discusses the current state-of-the-art methods in dairy fertility 
management, and describes how milk progesterone measurement can be used 
in this area. It also discusses possible technologies for development into an 
online progesterone biosensor, before outlining the specific aims of this 
research. The materials and methods are described in Chapter Three. Chapter 
Four presents the methodology and results of each trial, and Chapter Five gives 
an overall discussion of the findings. The conclusions and recommendations 
from the research are presented in Chapter Six. 
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Chapter 2 Dairy Cow Fertility Management 
This chapter presents the literature on the current state-of-the-art methods in 
dairy fertility management, and describes how milk progesterone 
measurement can be used in this area. It then goes on to discuss possible 
technologies for development into an online progesterone biosensor. Finally, it 
outlines the specific aims of this research. 
2.1 Financial Implications 
Fertility management is a critical aspect of dairy farming. It has a direct effect 
on milk produced per cow per day, number of replacements produced, and 
rates of voluntary and involuntary culling (Britt, 1985). These all have a direct 
effect on profitability. For an average yielding cow, the net cost of one day’s 
delay in conception is estimated to be £2.41 in the period 85-100 days post-
calving and £5.02 in the period 146-175 days post-calving (Esslemont et al., 
2001). 
In recent years, dairy cow fertility has been declining at a rate of 
approximately 1% per annum. The decline has been attributed to factors such 
as: genetic selection for high yield cows; changes in nutrition targeting high 
yields; increasing herd sizes; and more crowded environments (Butler, 2000; 
Royal et al., 2000; Silvia, 2003). Improved reproductive management is 
required to compensate for this decline. 
2.2 Oestrus Detection 
One of the most important and difficult aspects of dairy reproductive 
management is detecting oestrus, which indicates when to inseminate. The 
most common technique used historically (and currently) is observing cow 
mounting behaviour. A cow that is ovulating will typically stand still and 
allow herself to be mounted by another cow, whereas a cow that is not 
ovulating will normally not stand still when mounted. The major drawback to 
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this approach is that it is labour-intensive, requiring constant monitoring of 
cows, and therefore not particularly reliable. 
Several systems that record evidence of standing mount behaviour have been 
developed to automate oestrus identification. These include tail chalk/paint or 
pressure-sensitive tags placed on the tailhead, which will be rubbed off or 
activated during mounting. KaMaR tags are pressure-sensitive and change 
colour when pressure is applied (Williamson et al., 1972) whilst the 
HeatWatch system records time and duration of mounting events on a 
computer (At-Taras and Spahr, 2001). These systems reduce the labour 
requirement, but there is a significant chance of false detection. 
There is a relationship between increased cow physical activity and oestrus, 
and pedometers have been used to measure the activity and predict oestrus 
(Koelsch et al., 1994a; At-Taras and Spahr, 2001; Cross et al., 2004). Semi-
permanent electronic intravaginal probes have been developed to measure the 
chemical and physical changes in the vagina during oestrus (Heckman et al., 
1979; Lane and Wathes, 1988; Kyle et al., 1998). Morais and coworkers (2006) 
developed a device to measure temperature and electrical conductivity. The 
intention was to implant the device in the vulvar tissue to detect these changes 
and identify oestrus. All of these technologies suffer because the variables 
measured can easily change for reasons other than oestrus. 
Milk temperature immediately from the udder has also been used to predict 
oestrus (Gil et al., 1997) although this can be affected by variables such as 
mastitic infection (Hillerton, 2000) and ambient temperature. 
The oestrous cycle of an entire herd can be synchronised using hormone-
impregnated implants. Examples of this technology include CIDR (Controlled 
Intravaginal Drug Release) and PRID (Progesterone Releasing Intravaginal 
Device) (Rathbone et al., 1998), which are implanted in the vagina and release 
hormones to prevent ovulation. A cow will ovulate shortly after the device is 
removed, so removing the devices simultaneously from the herd will 
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synchronise ovulation. This is undoubtedly a useful technology, but another 
method must be used to actually detect oestrus itself. It also involves putting 
hormones in the animal, thus raising potential ethical and food safety 
concerns.  
2.3 Pregnancy Testing 
Once a cow is inseminated, it is critical to identify successful conception. Early 
knowledge of a failed insemination allows re-insemination at the next 
ovulation, thus maximising reproductive efficiency. However, early detection 
of pregnancy can be confounded by embryonic loss at a later date 
(Rajamahendran et al., 1994) so further confirmation of the pregnancy later is 
advisable. Knowledge of the pregnancy-status of a cow is useful for herd-
management decisions such as culling. 
The most common technique for diagnosing pregnancy is palpating the uterus 
through the rectum. This approach has many drawbacks: it is labour intensive; 
the animal must be isolated and restrained and then inspected physically; a 
skilled practitioner (most commonly a veterinarian) is required for reliable 
results; the procedure can induce embryonic loss when not performed 
correctly; and the earliest useful diagnosis can be made at about 35 days post-
insemination. A non-pregnant cow will have ovulated again at about day 22 
(Romano et al., 2007). In practice, oestrus detection may well infer a non-
pregnant cow at day 22 so re-insemination can occur. Only cows that aren’t 
detected as ovulating would be palpated. However, detecting oestrus, for 
example by observing standing mount behaviour, is not reliable. Six percent of 
cows may exhibit standing mount behaviour during normal pregnancy 
(Sheldon and Noakes, 2002). 
Ultrasonography, also performed per rectum, can detect pregnancy earlier 
than palpation and there is no risk of damage to the foetus. However, the cows 
need to be isolated and restrained and a skilled practitioner is required (Ribadu 
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and Nakao, 1999). Pregnancy can be detected as early as day 21 under 
controlled experimental conditions, but day 25 is a more practical estimate. 
Thus, as for palpation, ultrasonography cannot detect non-pregnancy before 
the next ovulation. The cost of ultrasonography equipment ($8000-16000) is 
relatively small compared with the cost of poor reproductive management, 
especially if the cost is spread across many farms (Fricke and Lamb, 2005). 
Two pregnancy-specific trophoblastic proteins, Pregnancy Specific Protein B 
(PSPB) and Pregnancy Associated Glycoprotein (bPAG), have been identified 
in the maternal blood. These can be detected in a laboratory by immunoassay 
and are reliable indicators of pregnancy (Humblot, 2001). Pregnancy can be 
detected at day 25 and confirmed at any later stage in the pregnancy (Sheldon 
et al., 2006). The major drawback of this approach is that a blood sample is 
required. There appears to be no literature on these proteins in milk, which is 
far more accessible than blood. 
Another pregnancy-associated glycoprotein, Early Conception Factor (ECF), 
can be detected in the milk within 3 days of conception. Commercially 
available qualitative test kits are available (EDP Biotech Corp.), which claim 
“reliable detection of ECF to determine whether or not conception has 
occurred as early as 7 days after breeding”. However the literature suggests 
that the test is not yet reliable (Cordoba et al., 2001; Sheldon and Noakes, 
2002). 
Pregnancy-specific hormones such as oestrone sulphate are found in the milk 
and can also be measured by immunoassay and used to detect pregnancy. A 
test kit is commercially available (Confirm®, ICPBio). The disadvantage is that 
oestrone sulphate in milk cannot reliably indicate pregnancy until day 120 
(Henderson et al., 1994). 
 7
2.4 Progesterone 
Progesterone is a steroid hormone (Figure 1) produced in female mammals. It 
is secreted from the corpus luteum in the ovary, beginning shortly after 
ovulation, and its function is to prepare the uterus for pregnancy. If the egg is 
successfully fertilised, the corpus luteum will persist throughout gestation and 
the progesterone concentration will remain high (slightly elevated). If the egg 
is not fertilised, it will decay and the progesterone concentration will fall 
(Frobenius, 1999). 
H
HH
O
O  
Figure 1: Molecular structure of progesterone (4-pregnene-3,20-dione). 
2.5 Dairy Cow Fertility Management Using Progesterone 
Regular measurement of a cow’s milk or plasma progesterone concentration 
can be used to follow the oestrous cycle and applied as a general purpose 
reproductive management tool. Many studies have been completed examining 
the various uses of milk progesterone measurement to manage bovine fertility 
(for example: Laing and Heap, 1971; Dobson and Fitzpatrick, 1976; Laing, 
1976; Lamming and Bulman, 1976; Foote et al., 1979; Gunzler et al., 1979; 
McLeod et al., 1991; Petersson et al., 2006). 
Progesterone measurements are required every 3-4 days, and possibly more 
often near ovulation, to establish a progesterone profile for each cow to 
identify oestrus. Some example milk-progesterone profiles are shown in Figure 
2. When the progesterone concentration falls to very low concentrations in a 
non-pregnant cow, ovulation will occur soon afterward, so it is a good time to 
inseminate.  
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Figure 2: Examples of progesterone profiles for different fertility conditions. 
The arrows indicate the approximate day of ovulation for the cycling cow. 
(Source: Claycomb, 1996) 
After ovulation, the progesterone concentration will increase. If insemination 
is successful, the progesterone concentration will remain high throughout 
pregnancy. Failed insemination can be detected by progesterone measurement 
as early as day 21 when the next ovulation occurs. This is earlier than all other 
pregnancy detection methods described in Section 2.3 other than ECF. Any 
loss of the foetus is quickly followed by a fall in progesterone concentration.  
Because progesterone concentration directly reflects ovarian activity, an 
atypical progesterone profile can be used to detect possible fertility disorders 
associated with the ovary, although such disorders can also cause persistent 
high progesterone concentrations that may give false positives for pregnancy. 
Milk is a convenient fluid to sample for progesterone analysis and fertility 
management. The typical dairy cow will be lactating during the stages of the 
bovine reproductive cycle when it is most important to know the cow’s 
fertility status: start of the oestrous cycle after calving; insemination; and the 
early stages of pregnancy. Thus, daily milk samples can be obtained. Although 
the milk-matrix complicates the analysis and can introduce measurement 
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errors, the determination is still possible because progesterone’s affinity to 
milk fat makes the concentration in milk much higher than in blood plasma 
(Erb et al., 1977). 
2.6 Progesterone Measurement 
Chemical techniques for measuring progesterone were developed in the 1940s 
and 50s. They were typically based on solvent extraction, chromatography 
and/or spectrophotometric quantification (Edgar, 1953; Short, 1958). A radio-
assay for steroids developed in the 1960s (Murphy et al., 1963; Murphy, 1967) 
led to progesterone radioassays (Bassett et al., 1969; Demetriou and Austin, 
1971) and radio-immunoassays (Heap et al., 1976; Holdsworth et al., 1979). 
The development of enzyme-linked immunosorbent assays (ELISAs) (Engvall 
et al., 1971; van Weemen and Schuurs, 1971) led to many ELISAs for 
progesterone (for example: Dray et al., 1975; Arnstadt and Cleere, 1981; Sauer 
et al., 1981; Chang and Estergreen, 1983; Munro and Stabenfeldt, 1984). These 
ELISA formats allowed widespread use of progesterone analysis. A 
chemiluminescence immunoassay for progesterone was also developed (Miller 
et al., 1988). 
More recently, other immunoassay technologies have been used for laboratory 
progesterone analysis. Gillis and coworkers and Wu and coworkers (2002) 
have independently presented surface plasmon resonance assays for 
progesterone which were further refined (Mitchell et al., 2005; Gillis et al., 
2006). Ehrentreich-Förster and coworkers  have developed an assay for 
progesterone in whole blood using an integrated optical grating coupler. In 
2004, Tschmelak and coworkers developed a fluorescence-based progesterone 
assay using a RIANA optical biosensor (Tschmelak et al., 2004; Tschmelak et 
al., 2005; Käppel et al., 2007). The latter two technologies have extraordinarily 
wide dynamic ranges compared to typical ELISAs even when dealing with 
difficult sample matrices such as whole blood and milk. Of the methods 
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developed for progesterone, only Gillis and Tschmelak measured progesterone 
in milk with a view to using their technology for dairy reproductive 
management. However, any of these new technologies may have the potential 
to be developed into on-line milk progesterone sensors. 
Many cow-side progesterone tests, using samples directly from the cow, have 
been developed and many attempts have been made to use these and lab-based 
tests to manage dairy reproduction (Nebel et al., 1987; 1989). Most cow-side 
tests are simplified enzyme immunoassays, with several in a lateral-flow 
format (Laitinen and Vuento, 1996; Sananikone et al., 2004). Recently, two 
automated (off-line) progesterone EIA analysers were released . Off-line 
progesterone testing schemes have the main disadvantage of a high labour 
requirement for taking and coordinating samples and running the tests. The 
major breakthrough will occur if an economically-feasible fully-automated on-
line progesterone sensor is developed. 
Some technologies have been used to develop on-line milk-progesterone 
sensors. Koelsch and coworkers (1994) developed a sensor based on measuring 
surface mass change using the resultant frequency change of a 10-MHz quartz 
crystal. Claycomb (1996) developed an automated EIA that was successfully 
used to monitor the progesterone profiles of four cows. In 2001, Pemberton 
and coworkers (2001) developed an electrochemical thin-layer continuous-
flow progesterone sensor. However, none of these technologies has been 
successfully commercialised, mainly because they are complex and/or 
expensive. 
2.7 On-line Progesterone Biosensor Requirements 
The milking environment is very different from carrying out off-line tests in a 
laboratory, where biosensing techniques have been developed. This is why 
attempts to develop an on-line milk-progesterone biosensor have been limited, 
and not yet commercialised.  
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Any sensor will need to be simple and robust, cheap to manufacture and run, 
rapid and accurate. The ability to link to electronic animal identification is a 
necessity. 
2.7.1 Simplicity and Robustness 
Most attempts at on-line progesterone measurement have been very complex. 
The milking environment is generally unsuitable for complex laboratory 
instrumentation, which is designed to sit on a solid bench in a dry 
temperature-controlled room. It is nearly always wet, the plant tends to shake 
during operation and the operating temperature may vary from below 0°C to 
above 40°C. 
The biosensor needs to be designed for the operating conditions. The 
components need to be robust enough to tolerate vibration and shaking, and 
operate for long periods (up to a year) without requiring technical input. 
Therefore, the number of moving parts should be minimal and the design 
simple. 
Any components sensitive to vibration need to be protected and if the assay (or 
any of the components) is temperature-sensitive, the internal temperature 
needs to be controlled or compensated for. 
2.7.2 Cost 
Most New Zealand milking systems are in a herringbone or rotary format, 
with many sets of teat-cups. For example, a 700-cow farm might have a 50-bail 
rotary system with 50 sets of teat-cups. If a sample is being collected from a 
given cow on average every third day (every sixth milking), there would need 
to be an on-line progesterone sensor at every sixth bail (i.e. a total of eight 
sensors). This means that the capital cost of the sensor must be very low 
compared with typical laboratory instrumentation that could process all the 
samples from many farms. 
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One potential market sector does not have quite as stringent a requirement on 
low capital cost. Automatic milking systems (AMS) are becoming more 
common in Europe and North America. These have a robotic cup-attachment 
system and milking can occur at any time of day. A single robot can service 
about 60 cows, each being milked up to three times daily (Australian National 
Milk Harvesting Centre, 2003). A 700-cow farm would require twelve AMS, 
only two of which would need a sensor to obtain the milk sample from a 
specific cow at a three-day average interval. This makes the AMS market a 
better target sector than the conventional milking parlour. In addition, AMS 
owners have already demonstrated they are keen to embrace new technology 
and may be more receptive to the idea of on-line progesterone sensing. 
Running costs also need to be low. A 700-cow herd involves over 20,000 tests 
in a three-month mating season. The cost of each test must be very small to 
off-set the advantages gained with better reproductive management. 
Consumables need to have a long-lifetime or be very cheap. The number of 
reagents needs to be minimised to minimise complexity. Any reagents need to 
be cheap and minimal quantities should be used. Thus, high-cost protein 
reagents are undesirable. 
2.7.3 Speed 
Data from the progesterone sensor should be available before the end of the 
cow milking so an ovulating cow can be automatically drafted into a holding 
pen for insemination. If the analysis took longer, the farmer would need to 
fetch the cow from the paddock or wait until she returned for the next milking 
before she is drafted, possibly missing the best time for insemination. 
In New Zealand, a typical milking may last five to six minutes. Completing an 
assay in five minutes is very fast by laboratory standards. The sample will need 
to be taken as soon as possible after milking starts and this may have a 
detrimental effect on test accuracy.  
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The fat content of dairy cow milk is lowest at the start of the milking and 
progesterone has an affinity for milk-fat (Erb et al., 1977) so samples taken at 
the start of the milking tend to have a lower progesterone content. This makes 
it more difficult to differentiate high and low progesterone concentrations for 
an individual cow. However, ELISAs have been used successfully to follow the 
oestrous cycle using samples of fore-milk (Holdsworth et al., 1980; Claycomb, 
1996). 
2.7.4 Accuracy 
The result from the biosensor does not need to be compared between cows or 
between farms. The most important requirement is to follow each cow’s 
oestrous cycle so the ‘low’ level of progesterone can be reliably detected. Thus, 
the biosensor needs to indicate only a relative value rather than the actual 
progesterone concentration, so the accuracy of the biosensor can be lower than 
required in a laboratory assay. 
2.7.5 Environmentally-Friendly Waste 
To avoid requiring special storage and disposal procedures, any waste from the 
sensor should be environmentally safe and able to be disposed of with shed 
waste (cow excrement). Otherwise, running costs will increase. 
2.7.6 Electronic Cow Identification and Data Recording 
To be commercially successful, it is essential that the assay is linked to 
electronic cow identification (EID) and data recorded using a herd 
management system (HMS). Data from a progesterone test needs to be viewed 
in the context of recent data from that cow. This means that a database needs 
to be built so the progesterone profiles for individual cows can be analysed. 
The best way to match the test result to a specific cow is with EID and a HMS. 
These are becoming more common in conventional milking systems and are 
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required in AMS. Farmers investing in on-line progesterone sensing are likely 
to be keen users of technology and already have an EID/HMS system. 
More pertinent for applicability of progesterone sensing is having tools to 
analyse the data and display the profiles so the farmer can make reproductive 
management decisions. As this would be labour intensive, the analysis 
software should also be able to make decisions for the farmer, even to the 
extent of being able to automatically draft cows for insemination. 
2.8 Possible Technology Platforms 
Table 1: Characteristics of five technologies with potential as an on-line milk-
progesterone biosensor. 
 SPR 
(Biacore) 
OWLS TIRF Traditional 
ELISA 
ELISA as a 
column of 
beads 
Simplicity Low Low Low High Medium 
Temperature stability Low Low Medium Medium Medium 
Vibration stability Low Low Medium High High 
Suitability for 
automation 
High High High Low High 
Capital cost High Medium Medium Low Low 
Running cost High Medium Medium Medium Medium 
Speed High Medium High High High 
Dynamic range Medium High High Medium ? 
Availability of 
technical know-how 
Low Low Low High Medium 
Multiple analytes 
possible 
Yes No Yes No No 
The traditional way to measure progesterone is with ELISA. In addition, three 
relatively new technologies identified in the literature have potential as an 
automatic progesterone biosensor – surface plasmon resonance (SPR), optical 
waveguide lightmode spectroscopy (OWLS), and total internal reflection 
fluorescence (TIRF). The characteristics of these technologies, along with the 
traditional ELISA and ELISA as a column of beads are summarised in Table 1 
and discussed in the next sections. 
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2.8.1 Surface Plasmon Resonance (SPR) 
The SPR phenomenon (Figure 3) occurs when polarized light, under 
conditions of total internal reflection, strikes an electrically conducting gold 
layer at the interface between media with different refractive indices - the 
glass of a sensor surface (high refractive index) and an aqueous solution (low 
refractive index). For a given wavelength at a certain angle of incidence (the 
resonance angle), a plasmon wave is excited in the conductive surface and 
propagates along the surface. The resulting decrease in reflected intensity is 
used to identify the resonance angle and thus changes in refractive index at or 
near the gold surface (Biacore, 2007). When large molecules such as proteins 
bind to the surface, the local refractive index increases, which means binding 
events can be detected in real-time. 
 
Figure 3: Principles of SPR sensing. 
(Source: Biacore, 2007). 
To measure progesterone, the chip surface is coated with progesterone and the 
sample is mixed with antibody and passed across the surface (Gillis et al., 
2002). Free antibody (not bound to the progesterone in the sample) binds to 
the progesterone on the surface causing a measurable response inversely 
correlated with the progesterone concentration of the sample. 
SPR-based biosensors such as the Biacore instrument (Biacore, Sweden) are 
now widely used in laboratories to quantify a wide range of analytes in a wide 
range of sample matrices including milk. This technology is very flexible. The 
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Biacore flow cell has four channels in contact with the gold surface so four 
analytes could be measured simultaneously with a single sample injection. This 
means progesterone and other useful analytes such as antibiotics or even 
bacteria could be measured from a single sample. Furthermore, the instrument 
is flow-through so it could be easily automated. 
The SPR assay developed by Gillis and coworkers (2002) is sensitive enough to 
follow a cow’s oestrous cycle, and fast enough to meet the requirements for an 
on-line assay. Unfortunately, in its current form the Biacore instrument and 
associated consumables are too expensive for this assay to be used as an on-line 
biosensor. Also, the equipment needs to be in a controlled temperature 
environment because refractive index (and therefore SPR) is temperature 
dependant. It would also need to be isolated from vibrations in the milking 
system, which would probably interfere with the ability to accurately measure 
very small changes in resonance angle. These disadvantages mean SPR may be 
unsuitable for the farm environment. 
2.8.2 Optical Waveguide Lightmode Spectroscopy (OWLS) 
Like SPR, OWLS detects mass change at the sensor surface. The basic principle 
involves coupling linearly polarized light (He-Ne laser) via a diffraction grating 
into the waveguide layer at a precise angle of incidence, which depends on the 
refractive index of the medium covering the surface of the waveguide. The 
coupled light is guided by total internal reflection to the photodiode detector 
at the end of the waveguide . 
An alternative configuration (Figure 4), which determines the resonance angle 
with a CCD-array, has been used to measure progesterone in whole blood . 
This assay has a very wide dynamic range and is relatively fast, taking 15 
minutes for a full cycle including regeneration. Because the technique has 
worked with whole blood, it is probably a robust technique that could also 
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work with milk. The instrument seems to be a relatively straightforward 
design that could be implanted into an on-line sensor. 
 
Figure 4: Principles of OWLS. 
At the resonance angle, the reflected intensity detected at the CCD-array is 
minimised. I is the evanescent part of the field above the surface; II is the field 
distribution in the waveguide; and III is the underlying support. 
 
Optical Waveguide Lightmode Spectroscopy instruments are commercially 
available. BIOS-1 from Microvacuum (Budapest, Hungary) is an example. As in 
SPR, OWLS depends on refractive index and resonance angles, so it may also 
be susceptible to temperature variation and vibrations. Both instruments are 
flow-through systems suitable for automation but OWLS is probably cheaper 
and more available for development than SPR (Biacore). However, to develop 
a satisfactory assay that could be used on-farm probably requires collaboration 
with the developers. 
2.8.3 Total Internal Reflection Fluorescence (TIRF) 
The TIRF instrument used by Tschmelak and coworkers (2004) to develop a 
progesterone assay was a RIANA instrument designed by a consortium of 
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European universities and industries to measure pesticides and trace-amounts 
of chemicals in rivers and waterways. A laser beam (excitation light) is coupled 
into the transducer and propagates by total internal reflection (Figure 5). 
Fluorescent markers bound to the surface are then excited in the evanescent 
field and emit light, which is measured perpendicular to the surface ( Brecht et 
al., 1998; Barzen et al., 2002). 
 
Figure 5: Principles of TIRF sensing. 
(Source: Brecht et al., 1998). 
Other than the antibody being labelled with a fluorescent marker, this assay is 
very similar to the SPR and OWLS progesterone assays in that the marked 
antibody is mixed with the sample and passed across the surface. The SPR and 
OWLS assays detect bound mass whereas the TIRF assay detects the bound 
marker. The RIANA can measure multiple analytes because the laser reflects at 
six spots on the slide. Each of these points could measure a different analyte. 
The results reported in the literature for progesterone analysis are very good, 
with a 5-minute assay time and a wide dynamic range. Like SPR and OWLS, 
the RIANA is a flow-through system, making it suitable for automation, but 
the RIANA does not involve precise measurement of a resonance angle or 
require a stable refractive index of the flowing liquid so this technology is a 
more robust option for the milking environment than SPR or OWLS. Overall, 
the RIANA is promising technology platform for on-line progesterone sensing 
but it is still a complex instrument, so there may be technical issues to 
overcome, which will require cooperation with the inventors. 
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2.8.4 Enzyme-Linked Immunosorbent Assay (ELISA) 
The development of the ELISA format in the 1970s represented a major 
milestone in assay technology. Analytes at ng/mL concentrations could be 
determined in just a few hours without using hazardous radioactive reagents. 
Furthermore, it led to the development of portable test kits such as home 
pregnancy tests and cow-side progesterone tests. It is currently the 
predominant technology for milk-progesterone testing. 
ELISAs take many formats, but all involve covalently binding an enzyme to an 
antigen or antibody and some method of binding the conjugate to a solid 
surface to allow detection by the addition of a substrate. The proportion bound 
depends on the analyte concentration. 
Antigen approaches 
the antibody surface.
Antigen-enzyme 
conjugate approaches 
antibody surface, a 
portion of which 
already has bound 
antigen. 
Substrate approaches 
antibody surface, a 
portion of which has 
bound antigen-
enzyme conjugate. 
A portion of the 
substrate has reacted 
with the bound 
enzyme and changed 
colour. 
Figure 6: A typical progesterone ELISA. 
In a typical progesterone assay (Figure 6), anti-progesterone antibody is 
immobilised on the surface. The sample is exposed to the surface and the 
progesterone (antigen) in the sample binds to the antibody. A progesterone-
enzyme conjugate is then exposed to the surface and the progesterone already 
bound limits the amount that can bind to the immobilised antibody. This is 
known as a competitive assay. A substrate is then exposed to the surface and 
the colour change depends on the amount of bound enzyme, which is 
inversely correlated with the progesterone concentration in the sample. 
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ELISAs are normally carried out on many samples simultaneously in a 96-well 
microtitre plate. Reagents are pipetted into the wells and manually discarded. 
The optical density is measured using a plate reader (a spectrometer), which 
measures the transmission through every well. Although the assays normally 
take several hours, the manual work involved is only a small part of this time. 
The major advantage of ELISA is the relative simplicity of the detection 
system. While newer technologies such as SPR, OWLS and TIRF use laser 
light, tightly controlled angles, sophisticated sensor surfaces and advanced 
optical detection systems, ELISAs simply measure the optical density by 
shining (non-laser) light through the liquid. This is far better suited to the 
milking environment. 
The main disadvantage is that the traditional plate format is not flow-through, 
and therefore unsuitable for automation. A second disadvantage is that it 
requires a substrate. This extra reagent significantly increases assay complexity, 
which may negate the simplicity of the detection system. 
Claycomb (1996) overcame these issues and developed an on-line progesterone 
biosensor based on this principle. He also modified the assay by adjusting 
reagent concentrations, which reduced assay time to less than 5 minutes. The 
biosensor was successfully used to follow the oestrous cycles in three cows, to 
detect an acyclic cow with cystic ovaries, and the progesterone levels in a 
pregnant cow. Although the sensor was too complex and expensive for 
commercialisation, Claycomb’s results demonstrate that an ELISA-based 
system has the potential to meet both the speed and precision requirements of 
an on-line progesterone biosensor. 
2.9 Beads in Immunoassay Systems 
Immunoaffinity columns are widely used for purifying and/or concentrating 
proteins from complex mixtures. Pre-activated media with active groups that 
readily react to form covalent bonds with a ligand are available from most 
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media suppliers (for example: Rapp-Polymere, Germany; GE Healthcare-Life 
Sciences, UK). The ligand can be chosen to interact specifically with the target 
molecule and separate it from the mixture (Scopes, 1993). Depending on the 
stability of the bound molecule, the media can be used repeatedly. For 
example, Acevado and coworkers (2006) immobilised anti-PSA antibody in a 
Sepharose CL-4B matrix and packed the gel into a column to purify a protein 
called prostate specific antigen (PSA) from human seminal plasma. 
Using beads for immunoassays is not a new concept. Catt and coworkers (1966) 
covalently coupled antibody to an isothiocyanate derivative of a styrene-
polytetrafluoroethylene copolymer and used a suspension of the beads in a 
radioimmunoassay (RIA) for human growth hormone. Goodfriend and 
coworkers (1969) entrapped antibody in a cross-linked acrylamide polymer 
and used a suspension of the resulting granules to determine angiotensin by 
RIA. Brooker and coworkers (1976) used an anion exchange column to 
separate bound antigen from free antigen in RIA. This ‘Gammaflow’ system 
was completely automated and not analyte specific, so was very flexible. Ismail 
and coworkers (1978) described the ‘Southmead System’, which incorporated a 
Sepharose-linked antibody and was applicable to RIA, EIA and 
fluoroimmunoassay. Rather than using a column format, they mixed the beads 
in suspension and later filtered them out. Gray and Keyes (1981) patented a 
column-based enzyme immunoassay method, which involved pre-saturating 
the column with enzyme-antigen conjugate. The antigen-containing sample 
released the bound enzyme, which was quantified using an immobilised 
substrate.  
Many bead-based immunoassays have been described recently, but the beads 
are usually suspended in the reaction fluid and then separated magnetically or 
by filtration. An example is an on-bead assay for identifying substrates for 
protein tyrosine kinases, which involves slurrying the beads and the reactants 
(Martin and Peterson, 2002). Such systems are not suitable for a rapid, 
automated, repeated-use, on-line assay. 
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2.10 Project Outline 
2.10.1 Objective 
Enzyme-antibody 
conjugate 
Sample containing 
progesterone 
Sample-conjugate 
mixture 
Substrate 
Substrate changes 
colour when it 
interacts with the 
bound conjugate 
Free conjugate 
binds to the 
immobilised 
progesterone 
Figure 7: Column-of-beads ELISA concept. 
This project aimed to transfer an ELISA for progesterone to a robust, readily-
automated flow-through format that maintains the advantage of simplicity of 
detection (Figure 7). The solid phase, which supports a progesterone-derived 
antigen, is a column of beads. The milk sample is mixed with a solution 
containing an enzyme-anti-progesterone conjugate, which effectively binds all 
the milk progesterone. When this mixture is passed through the column, the 
remaining free conjugate is bound to the solid phase. A substrate for the 
conjugated enzyme is then passed through the column and the colour change 
is inversely proportional to the concentration of milk progesterone. 
The advantage of this format over plate-based ELISAs is that the reagents are 
forced to contact a large active surface. The flow-through nature of the column 
allows individual samples to be analysed quickly. 
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2.10.2 Solid Phase 
Unlike typical progesterone ELISAs, the assay would immobilise the antigen 
rather than the antibody. This has the potential to give a more stable and 
longer-life column because progesterone is very stable compared with 
antibody. More aggressive regenerants can be used without the risk of 
damaging the active surface. The immobilised antigens used in the SPR, TIRF 
and OWLS progesterone assays (Section 2.8) had very long life times (Gillis et 
al., 2002; Wu et al., 2002; Ehrentreich-Förster et al., 2003; Tschmelak et al., 
2004). This suggests that immobilised antigen assays for progesterone are 
viable and that regeneration is reliable. 
A possible disadvantage of a progesterone-coated surface is that steric 
hindrance might prevent optimal binding of antibody, especially if a blocking 
agent is required to minimise non-specific binding. This will need to be 
investigated. 
An important consideration for dealing with milk samples is bead size. Bovine 
milk contains fat globules up to about 10 μm diameter (Rogers, 1928), which 
could clog a column. Larger beads allow the fat globules to pass through the 
column, particularly if the temperature is close to cow temperature (38°C) so 
the fat is liquid. This will minimise clogging, but smaller beads have a larger 
surface area to volume ratio and are more efficient at capturing antibody. A 
balance between the two factors is required. 
2.10.3 Verifying Antibody-Enzyme and Antigen-Surface 
Coupling 
The primary reagent in the assay is an antibody-enzyme conjugate, which 
needs to be specially created for this project. Anti-progesterone antibody will 
be covalently coupled to horseradish peroxidase (described in Section 3.3.2). 
The other prerequisite chemical reaction covalently couples the antigen to the 
bead surface (described in Section 3.3.4). 
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Successful coupling needs to be verified for both these reactions before the 
products can be used with confidence. Mass-dependent protein purification 
techniques, such as size-exclusion chromatography or gel-electrophoresis, 
could be used to qualitatively assess the success of conjugation. But the real test 
is whether molecules that bind progesterone also catalyse the substrate 
reaction. It is tempting to think that both the conjugation and the bead-
coating can be verified in a single experiment where the conjugate is exposed 
to coated beads, and then the beads are rinsed and exposed to substrate, which 
reacts with bound enzyme. However, a more reliable approach would be to 
first demonstrate a successful bead coating using a system such as Biacore SPR 
with a surface sensitive to anti-progesterone antibody. The bead-coating can 
be verified by exposing antibody to the beads and comparing the SPR-response 
of the eluant with that when antibody is exposed to uncoated beads. 
Conjugation can be verified by showing that coated beads exposed to the 
conjugate catalyse the substrate reaction, whereas uncoated beads do not. 
2.10.4 Assay Parameters 
Once the success of conjugation and bead-coating has been verified, the 
column can be packed and the assay set up. The column of beads concept can 
be tested using a laboratory liquid chromatography (LC) system. If an in-line 
630 nm detector is not available, the eluted substrate can be collected and 
analysed in a spectrometer. The LC system will allow approximate assay 
parameters to be set up and tested in a controlled environment. The 
parameters to investigate include conjugate concentration, sample to conjugate 
mixing ratio, substrate concentration, pH and buffer concentration, 
regenerant, flow rates of each step, and column size. 
The LC system can also be used to assess assay robustness against key variables 
for an on-line milk progesterone sensor. Initial testing would use spiked 
aqueous samples, but spiked milk samples would eventually be used to adjust 
the assay parameters for milk and to assess whether milk clogs the column. 
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Clogging is probably temperature dependent, so temperature would be 
controlled. The effect of temperature changes on the assay also needs also be 
determined so temperature tolerances can be specified. In summary, the 
sensitivity of the assay to all parameters listed above needs to be determined, as 
well as the effect of milk composition. 
2.10.5 Reagent Formulation 
At least four reagents are required for this assay: conjugate, substrate, 
regenerant, and running buffer; as well as the sample. A separate running 
buffer may also be required for the substrate reaction. Storing and disposing of 
these reagents is likely to be a major hurdle when transferring the assay from 
the laboratory situation to the farm, so reagents used in laboratory experiments 
should be selected with this in mind. Initial experiments should be done using 
reagents we have confidence in, but we should switch to farm-suitable 
formulations as soon as possible in the development process. 
The conjugate is a protein and therefore susceptible to degradation at elevated 
temperatures and in the presence of microbial or oxidative contaminants. 
Losses may be exacerbated at low concentrations. As the concentration will be 
set to optimise the assay, ideal storage conditions would be approximately 4°C, 
with a stabilising protein such as BSA, a preservative to minimise microbial 
growth, and a reducing agent to minimise oxidation. These conditions 
maximise the storage life of the conjugate and minimise the reagent reservoir 
refill frequency. However, having a refrigerated storage container increases 
sensor complexity, so there is a trade-off between a longer storage life and a 
cheaper, simpler device. 
The tetramethylbenzidine (TMB) substrate is light and temperature sensitive 
and is normally mixed with hydrogen peroxide immediately before use. It can 
easily be stored in a light-proof reservoir, but the refrigeration issues already 
discussed are a bigger hurdle. Where possible, commercial, ready-to-use TMB 
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substrate formulations should be used in the laboratory phase, but they still 
require refrigeration. Another problem with TMB is disposal. The MSDS 
(Sigma, 2004) states that TMB should be disposed of by a licensed professional 
waste disposal service, which will add significantly to the running costs. 
Alternative common peroxidase substrates (see Section 3.1.2) are no better. 
The buffer solutions and regenerant require preservatives to prevent microbial 
growth. This preservative should be environmentally safe to minimise the 
volume of waste requiring specialist disposal. 
2.10.6 Calibration 
Laboratory assays can run a full calibration curve of standard concentrations 
alongside the test samples, allowing an accurate estimate of the concentration 
in the samples. This approach is not feasible for the on-line milk progesterone 
sensor. Firstly, we need to minimise the number of reagents to minimise 
complexity. Secondly, supply of milk standards is difficult. Standards made 
from UHT pasteurised milk, could be stored as long as the container remained 
sealed, but a reliable supply of ‘representative’ progesterone-free milk is 
needed to make the standards. This would be difficult. 
An alternative to running a full calibration curve is to use positive and 
negative blanks to normalise the response. The negative blank sample would 
involve running buffer with no added conjugate. This would emulate a high-
progesterone-concentration sample and represents the minimum response of 
the system. It may not need to be run often. The positive blank would be 
running buffer mixed with conjugate in the same ratio as for a real sample. 
This would emulate a low-progesterone-concentration sample and represents 
the maximum response of the system, thus correcting for variation/degradation 
in conjugate binding/enzymatic activity, surface activity and substrate activity. 
These parameters are more likely to change, so the positive blank would need 
to be run regularly. It is likely that the milk matrix could shift the results 
 27
outside the calibrated range, but this should not matter as long as it is 
repeatable. There must be inter-sensor consistency between the normalised 
value and the progesterone concentration. This calibration scheme uses no 
specific calibration reagents and therefore minimises system complexity. The 
calibration system is a very important component of the assay system so the 
concept needs to be tested early in the project. 
2.10.7 Physical Design 
The physical design of the biosensor would be finalised later in the 
development process, after most of the assay parameters and reagent storage 
conditions have been optimized/determined. Although the design is outside 
the scope of this research project, possible designs should be considered, as 
they will influence the decisions made. 
The sample, conjugate and reagents need to be mixed and forced through the 
column in a controlled fashion. Laboratory pumps such as syringe pumps are 
expensive and may be unsuitable for the milking environment. Peristaltic 
pumps are a more robust alternative, but have poorer flow-rate control and the 
flow is pulsed rather than smooth. Pulsed flow may be detrimental for 
chromatography, but less critical for our assay. 
Mixing the reagents and switching between reagents is not a trivial matter. 
Liquid chromatography systems typically use expensive, high-pressure valves. 
The on-farm assay is unlikely to be operating at high pressure so cheaper 
alternatives may be possible to obtain or custom-design. 
Temperature control of the sensor is a major project. The column will probably 
need to be heated to 38°C during operation. Depending on reagent storage 
requirements, some reagents may need to be cooled. Temperature control may 
be obtained using solid-state Peltier devices that act as heat pumps. 
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The detection system required for an ELISA-based biosensor (Section 2.8.4) is 
much simpler, more robust and better suited to the milking environment than 
any of the other technologies discussed. The envisaged system would use a red 
LED emitting at about 630 nm with a narrow emission angle aimed at a 
photodiode on the other side of the fluid. The red light would be absorbed by 
the blue reacted substrate. 
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Chapter 3 Materials and Methods 
3.1 Reagents 
3.1.1 Enzyme 
Current popular enzyme labels for ELISAs include horseradish peroxidase 
(HRP), alkaline phosphatase, β-galactosidase (Sigma, 2000) and glucose oxidase 
(Hermanson, 1996). The single-chain polypeptide glycoprotein HRP (Table 2) 
was selected because it is the smallest and most stable. Its precise carbohydrate 
and amino acid composition depends on the specific isozyme (Shannon et al., 
1966; Clarke and Shannon, 1976). Lyophilised HRP (P8375; Sigma) was 
supplied by Biolab (Auckland) and stored at room temperature. 
Table 2: Properties of HRP. 
Property Value 
Molecular weight (including carbohydrate) 
Carbohydrate content 
No. of isozymes 
Disulphide bridges 
Primary amine groups 
Isoelectric point (depending on isozyme) 
Optimum RZ* for conjugation to proteins 
Optimum pH 
Stable pH range 
Storage (powdered) 
Storage (suspension) 
40 kDa 
18% 
≥ 7 
4 
2 
3.0 - 9.0 
≥ 3.0 
6.0 - 6.5 
5.0 - 9.0 
< 0°C 
2 - 8°C 
Source: Sigma 2000, Hermanson 1996 pg 100. 
* Reinheitszahl (absorbance ratio A403/A275) is a measure of hemin content.  
3.1.2 Substrate 
HRP readily forms a complex with hydrogen peroxide (H2O2), which can then 
oxidise a wide range of chromogenic hydrogen donors. Several substrates are 
widely-used in HRP enzyme immunoassays (Table 3). Tetramethylbenzidine 
(TMB) was chosen for this study because it is the most commonly-used HRP 
substrate and because it was successfully used in the previously developed 
plate ELISA (Orchard, 2004). 
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Table 3: Typical substrates used with HRP. 
Substrate Structure Characteristics 
Measurement 
absorbance (nm) 
ABTS 
 
S
N
CH2CH3
HO3S N S
N
CH2CH3
SO3HN
 
Light-sensitive 
More stable in 
absence of O2
410 
650 
OPD 
 
NH2
NH2
 
 
Health risks 
Use within 1 h 
450 
TMB 
 
H2N NH2
.2HCl  
 
Most sensitive 
Most common 
Light-sensitive 
370 
655 
o-dianisidine 
 
H2N
H3CO OCH3
NH2
 
 
Light-sensitive 
Health risks 
405 
5AS 
 
COOH
OH
H2N  
 
 450 
ABTS - 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) 
OPD - o-phenylenediamine 
TMB - 3,3’5,5’-tetramethyl-benzidine 
5AS - 5-aminosalicylic acid 
Powdered TMB (P8375; Sigma) was supplied by Biolab (Auckland), made to 
0.2 mg/mL in 1:3 methanol:water (Appendix 1) and stored in the fridge. 
Immediately before use, it was diluted to 0.1 mg/mL in phosphate-citrate 
buffer (pH 5.0) with 0.006% hydrogen peroxide. 
In an on-farm situation, it is not feasible to prepare the substrate solution 
immediately before use without increasing device complexity. Fortunately, 
ready-to-use TMB formulations that do not require any additives are available. 
For example, Sigma T0440 is a ready-to-use, one-component liquid substrate 
solution. It still has the significant drawback that it must be stored at fridge 
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temperature and used at room temperature. The ideal substrate would be 
stored ready-to-use at room temperature. 
3.1.3 Antibody 
Several factors need to be considered when selecting an antibody. Firstly, the 
antibody must have good selective binding for both the bound and free 
progesterone. Secondly, it must give relatively repeatable results from batch to 
batch and there must be some assurance that it will be available commercially. 
Thirdly, it must be relatively cheap. 
Polyclonal antibodies are raised by an immune response in a small mammal 
(for example a rabbit). Because progesterone is a hapten, some form of 
conjugated progesterone, normally progesterone-BSA, must be used to induce 
the immune response. Thus, the antiserum will contain a population of 
antibodies, many of which will not bind free progesterone. The antiserum is 
normally purified by immunoaffinity chromatography to select only those 
antibodies that bind progesterone. Nonetheless, each antiserum batch will 
have a unique antibody combination. 
Monoclonal antibodies are always raised from the same bacterial culture so the 
antibodies are uniform and identical between batches. Although the initial 
immune response is initiated by a progesterone conjugate, the antibody 
selected for immortalisation is specific to progesterone. Monoclonal antibodies 
have the disadvantage of being more expensive than polyclonal antibodies. 
Despite the potential disadvantages of polyclonal antibodies, these were 
selected for initial trials in this project. The conjugated antibodies will be a 
high-use consumable in the biosensor, so cost is an important factor. 
Another important factor is location of conjugation of both the immunogen 
against which the antibodies were raised and the progesterone derivative to be 
immobilised on the column. Counterintuitively, the location of the two may 
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be different (Munro and Stabenfeldt, 1984), although this may be due to the 
purification process. For example, polyclonal anti-progesterone produced at 
UC Davis (USA) is raised against progesterone-11α-BSA and routinely used in 
combination with progesterone-3-HRP.  
This proven combination, sourced from a commercial supplier (Sigma P5289, 
anti-progesterone (pAb); and P3277, progesterone-3-carboxymethyloxime; 
both supplied by Biolab, Auckland), was initially selected for the project. 
Lyophilised polyclonal anti-progesterone powder was stored in the fridge until 
use. 
Later in the project, the monoclonal antibody used in the previously-
developed plate ELISA (Orchard, 2004) was used because it was known to 
interact with progesterone coupled at the 3-carbon. Monoclonal anti-
progesterone (mAb1-3 - CL425, batch 9/8/00, UC Davis, USA) was received as 
a 10.1 mg/mL solution and stored in one of two ways. 
• Storage method 1: mAb1 (rec’d 16 Jan 04) and mAb2 (rec’d 1 May 06) were 
diluted to 252.5 mg/mL in 0.05 M carbonate buffer (pH 9.6) and stored in 
0.5-mL aliquots. No preservative was included. The diluent buffer was 
prepared in 1-L glass bottles used for storing milk for unrelated work. The 
cleaning regime used for the glass bottles was not aggressive. These aliquots 
were thawed and diluted further for use. 
• Storage method 2: A new storage method was used for mAb3 (rec’d 10 Jul 
06) due to concerns about antibody stability. The antibody solution was 
divided into 10-μL aliquots and stored in the freezer. This meant the 
antibody was stored in its most concentrated form and not exposed to 
potentially contaminating buffers during long-term storage. When 
required, these aliquots were thawed and 490 μL of PBS was added to give 
a 202 μg/mL solution, which was stored in the fridge for further dilution as 
required. 
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3.1.4 Beads 
The ideal bead would be large enough to allow fat globules to pass through, 
small enough to allow sufficient surface area for binding, of a material that 
does not non-specifically bind antibody or enzyme, pre-activated to allow easy 
coupling of the ligand, with minimal steric hindrance of antibody-antigen 
interaction, and cheap. 
Tentagel™ Macrobeads (MB 300 02; Rapp-Polymere, Germany) were stored in 
a desiccator in the fridge. These 280-320 μm diameter polystyrene beads are an 
order of magnitude larger than beads typically used in immunoassays and were 
selected so fat globules could pass through. Trials need to be done to determine 
whether the beads are too large for sufficient binding, but even a very small 
column will have a much larger active surface area than the well of an ELISA 
plate. The Tentagel™ Macrobeads are available with a wide range of reactive 
groups, including amino, which is compatible with the carboxyl group of the 
P4-3CMO ligand. They cost $14/g, which is relatively cheap for 
chromatography media, considering a column uses only about 100 mg of beads.  
The main disadvantage of the beads is that polystyrene is renowned for non-
specific binding (NSB) of proteins, especially antibodies. It is commonly used 
for ELISA plates partly because of this property. Therefore, some form of 
blocking agent will probably be required to minimise NSB. This, in turn, may 
introduce steric hindrance of the antibody-antigen interaction. However, 
Tentagel™ Macrobeads have long ‘molecular tentacles’ of about 2000 Da 
(Figure 8), that may reduce any steric hindrance by ‘presenting’ the antigen to 
the antibody away from the blocked bead surface (Rapp-Polymere, 2003). 
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Figure 8: Chemical architecture of Tentagel™ Macrobeads. 
(Source: Rapp-Polymere, 2003). 
3.1.5 Coupling Reagents 
Covalent coupling techniques were used in three parts of this study. 
3.1.5.1 Coating Beads 
Beads were coated with progesterone-3-carboxymethyloxime (P4-3CMO, 
Sigma P3277) using an amine coupling technique (Section 3.3.4). The P4-
3CMO, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, Sigma E7750) 
and N-hydroxysuccinimide (NHS, Sigma 130672) were supplied by Biolab 
(Auckland). 
To stop these reagents being hydrolysed in the presence of moisture, they were 
stored under nitrogen in small aliquots in 2-mL plastic vials. The EDC aliquots 
were stored in the freezer in a desiccator and the NHS aliquots were stored at 
room temperature in a desiccator. 
3.1.5.2 Coating the SPR Chip 
The carboxyl surface of the Biacore CM5 chip was coated with P4-3CMO 
(Sigma P3277) using an amine coupling technique (Section 3.3.1.1). The Amine 
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Coupling Kit (Biacore BR-1000-50) was supplied by Bio-Strategy (Auckland), 
and ethylene diamine (Sigma E26266) was supplied by Biolab (Auckland). 
3.1.5.3 Enzyme-Antibody Conjugation 
The HRP was coupled to pAb and mAb2 using a periodate coupling technique 
(Section 3.3.2). Sodium periodate (Ajax A695) and sodium borohydride (Ajax 
A2334) were supplied by Biolab (Auckland). 
3.1.6 Other Reagents 
Low endotoxin bovine serum albumin (BSA, ABRE-001) was supplied by ICP 
Bio (Auckland). Progesterone-horseradish peroxidase (P4-HRP) was supplied 
by UC Davis (USA). All other reagents were research grade. Recipes for the 
solutions are in Appendix 1 and the suppliers are listed in Appendix 2. 
3.2 Equipment 
The Biacore 3000 SPR instrument (Biacore, Sweden) in the Mass Spectrometry 
Suite at the University of Waikato was used for SPR analysis. The Biacore CM5 
sensor chip was supplied by Bio-Strategy (Auckland). 
A Thermo Multiskan EX plate reader (51118170) supplied by Medica Pacifica 
(Auckland) with a 630-nm optical filter (1426300) was used to measure the 
optical density of substrate solutions on a Costar polystyrene microtitre plate 
(CST3590) supplied by Biolab (Auckland). 
Gel electrophoresis was carried out at AgResearch (Ruakura, Hamilton) on a 
Bio-Rad 4-15% linear-gradient 26-well 15-μL-comb gel (345-0029) in a Bio-
Rad Criterion Cell (165-6001) with a Powerpac 200 power supply. 
Protein solutions were analysed by size exclusion chromatography at the 
University of Waikato Engineering Department on an ÄKTA FPLC system 
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with a Superdex 200 10/30 column, UPC-900 controller, P-920 pump and 
UNICORN PC software (Amersham Pharmacia Biotech, Sweden). 
3.3 Methods 
3.3.1 SPR Antibody Activity Test 
3.3.1.1 Chip Preparation and Storage 
The method of Gillis (2002) was used to couple P4-3CMO to a Biacore CM5 
chip surface (Figure 9). Because the flow-cell used for automated coating was 
sensitive to the dimethylformamide (DMF) solvent, the coupling was done 
outside the sensor system by applying the solutions directly to the gold surface. 
The chip surface was first coated with ethylene diamine (EDA) to create an 
amine surface, compatible with the carboxyl group on P4-3CMO. 40 μL of a 
1:1 mixture of NHS solution (115 mg NHS in 10.0 mL deionised water) and 
EDC solution (750 mg EDC in 10.0 mL deionised water) was placed on the gold 
surface for 10 min to activate carboxyl groups on the surface. Then, 40 μL of 1 
M EDA pH 8.5 was placed on the activated surface for 20 min. One end of the 
EDA binds to the activated carboxyl groups and the other end provides the 
amine surface. Remaining active carboxyl groups were capped by applying 40 
μL 1 M ethanolamine pH 8.5 for 12 min. The surface was rinsed three times 
with 10 mM acetate buffer (pH 4.5). 
Once the amine surface was created, the progesterone derivative (P4-3CMO) 
could be coupled. 4.7 mg NHS and 11.1 mg EDC were dissolved in 1 mL 10 
mM acetate buffer (pH 4.5) and 450 μL of this activation solution was mixed 
with 900 μL DMF containing 2 mg P4-3CMO. After 5 min of activation, 40 μL 
of activated P4-3CMO solution was applied to the surface for 20 min. The 
finished surface was rinsed three times with acetate buffer and stored in a 
desiccator at 4°C. 
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Figure 9: Coating the SPR chip surface with progesterone. 
3.3.1.2 Test Routines 
Test routines were set up using the Biacore wizard. The entire chip was coated 
(rather than a pair of channels), so analyses were run through a single channel 
(channel 2) and no reference channel was used. The first routine used (Table 4) 
was the most simple and involved an initial baseline measurement, sample 
injection, a response measurement, and then a regeneration step.  
Table 4: Set-up parameters for SPR Test Routine 1. 
Flow rate 10 μL/min 
Baseline read 30 s before sample inject 
Sample inject 30 μL 
Response read 30 s before regeneration inject 
Regeneration inject 25 μL 
Final baseline read 30 s after regeneration inject 
This test routine was unsuitable for samples with large amounts of BSA. Some 
of the BSA would bind non-specifically to the chip surface, creating a much 
larger response which interfered with measurement of the antibody response. 
In conventional Biacore SPR procedures, uncoated channels would be run in 
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series so any response due to non-specific binding could be subtracted from 
the overall response. This approach could not be used because the entire chip 
surface was coated with antigen.  
Test Routine 2 (Table 5) was developed to cope with high BSA concentrations. 
It involved extra rinsing to remove the relatively loosely-bound BSA before 
recording the response, and an extended regeneration to ensure all BSA was 
removed before applying the next sample. Sections 4.34 and 4.35 describe the 
development of Test Routine 2. 
Table 5: Set-up parameters for SPR Test Routine 2. 
Flow rate 10 μL/min 
Baseline read 30 s before sample inject 
Sample inject 30 μL 
Flow rate 30 μL/min 
Wait 330 s 
Flow rate 10 μL/min 
Wait 30 s 
Response read 10 s before regeneration inject 
Regeneration inject 75 μL 
Final baseline read 30 s after regeneration inject 
3.3.1.3 Regeneration Routine 
To ensure a repeatable baseline before injecting the samples, a stand-alone 
regeneration routine was set up to run three times at the start of each session 
(Table 6). 
Table 6: Set-up parameters for the SPR Regeneration Routine. 
Flow rate 10 μL/min 
Baseline read 30 s before sample inject 
Regeneration inject 25 μL 
Final baseline read 30 s after regeneration inject 
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3.3.2 Conjugation 
3.3.2.1 Method Selection 
The carbohydrate moiety of HRP does not participate in the peroxidatic 
activity (Shannon et al., 1966) and provides a conjugation site that will not 
inhibit activity. Furthermore, HRP has only two terminal amine groups and is 
thus less suitable for typical amine coupling protein conjugations (Hermanson, 
1996). 
It is important not to inhibit the antibody-antigen interaction when coupling 
with the antibody. Several approaches are in general use, some of which 
specifically target non-interacting parts of the protein such as the disulphide 
bridges located in the hinge region. However, non-specific conjugation to 
amine groups is widely used (Hermanson, 1996). 
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Figure 10: Periodate activated conjugation and reductive amination of HRP-antibody 
conjugates. 
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In particular, conjugating HRP to antibodies is a very common activity and 
several conjugation techniques have been used successfully. This study used a 
protocol provided by Coralie Munro of UC Davis (USA) (Figure 10). HRP was 
activated for conjugation by sodium periodate oxidation, which generates 
reactive aldehyde groups that readily form a Schiff base with terminal amine 
groups on the antibody. The lack of amine groups on HRP minimises cross-
linking. The Schiff base was then reduced with sodium borohydride to form a 
stable amine linkage. Purification by dialysis was used after activation to purify 
the activated HRP, and again later to purify the final product. 
3.3.2.2 Method 
The HRP was coupled to pAb and mAb2 using a periodate coupling method 
based on the method of Munro and coworkers (1997). Lyophilised HRP (5.0 
mg) was dissolved in 1.2 mL deionised water and activated by adding 60 μL 
freshly prepared 0.1 M sodium periodate (in deionised water) and incubating 
for 45 min at room temperature. The activated HRP was dialysed overnight 
with two changes of 1 mM sodium acetate buffer (pH 4.4) at 4°C. After 
removing the solution from the dialysis tubing, 20 μL of 0.2 M sodium 
bicarbonate buffer (pH 9.5) was added to adjust the pH to between 9.0 and 9.5. 
Conjugation was achieved by adding 1.0 mL of 5.0 mg/mL antibody (in 0.2 M 
sodium bicarbonate buffer (pH 9.5)) to the activated HRP drop-wise with 
stirring and agitating gently for 2 h at room temperature. The Schiff base was 
reduced to form a stable conjugate by adding 90 μL of freshly prepared 4.0 
mg/mL sodium borohydride and agitating gently for 15 min at room 
temperature and 90 min at 4°C. The conjugate was dialysed overnight with 
two changes of 0.01 M phosphate buffered saline (PBS) (pH 7.0) at 4°C. 
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3.3.3 Conjugate Tests 
These methods were used to evaluate the success of conjugation. 
• Size Exclusion Chromatography (SEC): Chromatograms were obtained for 
40-μL aliquots of HRP-pAb, pAb and HRP using a Superdex 200 10/30 
column with PBS (pH 7.0) running buffer at a flow rate of 0.5 mL/min. The 
protein concentration was about 1 mg/mL. 
• SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE): Samples of HRP-
mAb2, mAb2 and HRP were run in parallel on a polyacrylamide gel. The 
4-15% Tris HCl gel was run for 50 min at 200 V. Coomassie stain was 
applied for 2 h followed by destain until the background was clear. 
• Surface Plasmon Resonance (SPR): The concentration of HRP-mAb2 was 
adjusted to an equivalent mAb2 concentration of 10 μg/mL and tested by 
SPR using Test Routine 1. The results indicate whether there is antibody 
activity in the HRP-mAb2 solution, but would not confirm conjugation 
unless the response was significantly higher than for unconjugated mAb2. 
Otherwise, the response could be caused by free unconjugated mAb2 in the 
solution. 
3.3.4 Coating the Beads 
The terminal amine groups on the solid phase are compatible with the 
carboxyl groups on progesterone-3-carboxymethyloxime (P4-3CMO). A 
simple amine coupling procedure (Figure 11) was used to permanently 
immobilise P4-3CMO on the beads. The carboxyl group was activated with a 
mixture of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-
hydroxysuccinimide (NHS), forming a succinimide ester. This then reacts with 
the amine group, covalently bonding P4-3CMO to the solid phase. There is no 
potential for cross-linking because there are no other carboxyl groups on P4-
3CMO or the beads. P4-3CMO was in molar excess to maximise the coating.  
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Figure 11: Immobilisation of progesterone-3-CMO to the bead surface. 
3.3.4.1 Bead Coating Method 1 
P4-3CMO was coupled to amine terminated ‘molecular tentacles’ on the bead 
surface with an amine coupling method based on the method used by Gillis 
and coworkers (2002) to coat a Biacore SPR chip. P4-3CMO (8.1 mg) was 
dissolved in 3.6 mL dimethylformamide (DMF). 450 μL activating solution (7.8 
mg NHS and 20.1 mg EDC in 10 mM acetate buffer (pH 4.5)) was then added. 
The Tentagel™ Macrobeads (97.8 mg) were added and the slurry was agitated 
for 40 min at room temperature. The beads were then rinsed with PBS (pH 
7.0). 
3.3.4.2 Bead Coating Method 2 
P4-3CMO was coupled to the bead surface using a method provided by Rapp 
Polymere (supplier of the beads). It utilised a three-fold higher P4-3CMO to 
bead ratio and a six to seven-fold higher bead to solvent ratio than Bead 
Coating Method 1. No water was used. 
P4-3CMO (23.5 mg) was dissolved in 600 μL 1:1 DMF:dichloromethane. Then 
NHS (7.1 mg) and EDC (11.9 mg) were added and the solution was incubated 
for 5 min to activate the carboxyl groups on P4-3CMO. About 100 mg beads 
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were added and the slurry was agitated overnight at room temperature. The 
beads were then rinsed with Regenerant 3. Control beads were prepared with 
the same method, omitting P4-3CMO, NHS and EDC. 
Note: Rapp Polymere recommended diisopropylcarbodiimide and hydroxyl-
benzotrizole instead of EDC and NHS respectively, but these were not used 
due to their hazardous nature. 
3.3.5 Bead Tests 
3.3.5.1 Transfer-Pipette Column 
To quickly evaluate the beads, a crude column was constructed from a 150-mm 
diameter glass transfer-pipette. Glass wool was packed into the pipette, beads 
were placed on top of the wool, and a final layer of glass wool was packed on 
top of the beads (Figure 12). The glass wool did not interact with the reagents 
and helped (1) prevent beads being washed away as liquid flowed through the 
column, (2) prevent beads floating up and clinging to the sides of the pipette 
and (3) to hold them in a packed formation.  
 
Figure 12: Transfer-pipette column for bead tests. 
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To use the column, 0.5-1 mL of liquid was added to the top, above the glass 
wool, and allowed to permeate through the column by gravity. Liquid was 
retained in the column due to surface tension, although the upper glass wool 
layer nearly completely drained. Eluant from each addition was collected in a 
vial below the column. 
3.3.5.2 Batch Testing Beads in a Test-Tube 
One drawback of the transfer-pipette column was that solutions did not 
contact the beads for very long. Also, contact could not be enhanced with 
agitation. To overcome this, beads were suspended in fluid in a 10 mL glass 
test-tube (Figure 13) and agitated on a shaker. This setup allowed the beads to 
be in contact with the solutions for extended periods. 
 
Figure 13: Test-tube set-up for bead tests. 
To replace the solution in the test-tube with a new solution: 
1. The beads were allowed to settle in the tube. 
2. Liquid was removed with a plastic transfer-pipette to the 2-mL line, being 
careful not to remove any beads. 
3. Fresh solution was added to the 10-mL line. 
4. Steps 1-3 were repeated several times to ensure the solution was 
sufficiently replaced.  
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The number of rinses chosen was based on the similarity between the two 
solutions and the importance of thorough rinsing. For example, when 
replacing regenerant with binding buffer, many rinses were required because 
the regenerant must be completely eliminated or it will damage the antibody 
or conjugate to be bound. When replacing pH 7.0 buffer with pH 5.0 buffer, 
the solutions are similar, so less rinses were required. 
The beads floated if the solution was very dense (such as Regenerant 1: 5M 
NaOH) or if air bubbles adhered to the beads. This made decanting very 
difficult and time consuming and some beads were inevitably lost. 
To expose the beads to a critical component (such as conjugate or substrate): 
1. The beads were rinsed with the same buffer solution as the critical 
component to ensure overall conditions after addition were appropriate. 
2. The liquid was decanted to the 2-mL line. 
3. 2 mL of the critical component was then added. 
If the critical component was an interacting component (such as conjugate or 
enzyme), the current solution was exchanged for PBS (pH 7.0), leaving 2 mL in 
the tube. Then 2 mL of conjugate/enzyme solution was added and stirred for 
10 min. If the critical component was the enzyme substrate (TMB), the current 
solution (normally conjugate or enzyme) was exchanged for phosphate-citrate 
buffer (pH 5.0), leaving 2 mL in the tube. Then 8 μL of 3% H2O2 and 2 mL of 
0.2 mg/mL TMB were added and stirred for 10 min. Duplicate 200 μL aliquots 
were placed in a microtitre plate well and read in a plate reader at 630 nm. 
Duplicate readings typically differed by less than 5%. 
The following procedure was used to regenerate beads by removing protein 
from the bead surface: 
1. The tube was filled to the 5-mL line with regenerant and agitated for 5 
min. 
2. The solution was replaced using the solution exchange method above and 
step 1 was repeated. Four cycles of regeneration were run. 
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3. The regenerant was exchanged for PBS for storage. The beads were stored 
in the test-tube in 2 mL PBS at 4°C. 
3.3.5.3 Batch Testing Beads in a Syringe  
The main problem of the test-tube batch method was the difficulty in 
separating beads from the solution. The beads are only slightly denser than 
water (buffer) so they sink slowly, are easily disturbed, and if a bubble adheres 
to them, they float. Beads were inevitably lost during the decanting process. 
This problem was overcome using the syringe method, which trapped the 
beads behind a filter that allowed only the solutions to pass (Figure 14). 
 
Figure 14: Syringe set-up for bead tests. 
 
Figure 15: Construction of the syringe bead test device. 
The device (Figure 15) was constructed by removing a high-density 
polyethylene filter from a 200-μL pipette tip (Raylab NZ, Auckland; CPBT200) 
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and wedging it into the top of a syringe needle (Biolab, Auckland; 
TER23643422). The modified needle was attached to a 3-mL syringe (Biolab, 
Auckland; TER23642170), creating a cavity from which beads could not 
escape. The plunger was removed and beads were loaded through the top of 
the syringe. 
To replace the solution in the syringe: 
1. The plunger was pushed down to the 0.5-mL line to eject most of the old 
solution and leaving the beads loosely packed. 
2. The new solution was aspirated by pulling the plunger up to the 2-mL line. 
This left the plunger in a stable position in the middle of the syringe. 
3. Steps 1-2 were repeated several times to ensure that the solution was 
sufficiently replaced. 
As previously, the number of rinses depended on the similarity of the two 
solutions and the importance of thorough rinsing. 
To expose the beads to a critical component (such as antibody or conjugate) in 
the syringe: 
1. The beads were first rinsed with the same buffer as the critical component 
to ensure conditions after addition were appropriate. 
2. The plunger was pushed down to the 0.5-mL line. 
3. The critical component was aspirated by pulling the plunger up to the 2-
mL line. 
4. The syringe was agitated gently by hand for a known time, which 
depended on the situation, to facilitate interaction between the beads and 
the solution. 
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Chapter 4 Assay Development 
This chapter describes the methodology used for each individual trial and 
discusses the results. 
4.1 SEC Conjugation Evaluation 
Polyclonal antibody (pAb) was conjugated to horseradish peroxidase (HRP) 
using the periodate conjugation method (Section 3.3.2). To evaluate the success 
of conjugation, conjugate (HRP-pAb) solution was passed through a size 
exclusion chromatography (SEC) column (Section 3.3.3). Unconjugated HRP 
and pAb solutions were run as controls. 
The chromatogram (Figure 16) indicated that a large amount of unconjugated 
HRP and pAb were in the HRP-pAb solution. However, this will probably not 
affect the performance of the proposed assay. Because excess HRP has no 
affinity for the antigen, it should not bind to the column and should be eluted 
with the progesterone-inhibited HRP-pAb. Excess pAb should bind to the 
column in the same relative proportion as HRP-pAb but, because it has no 
enzyme activity, it should not contribute to the colour change. However, the 
excess pAb may inhibit HRP-pAb binding to the column, which could affect 
the assay. Because there will probably be excess binding sites, this effect 
should be negligible. Calibrating the system should compensate for any effect 
of excess pAb. Overall, unconjugated material is probably not a significant 
problem. 
There was also a large amount of higher molecular weight material (Figure 17), 
presumably pAb and HRP conjugated to varying degrees. The molecular 
weight difference between pAb and HRP is 110 kDa and their peaks overlap 
slightly under the column conditions used. Each additional conjugated HRP 
molecule increased the molecular weight by only 40 kDa, which explains the 
limited resolution between pAb and HRP-pAb peaks. 
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This was only a qualitative evaluation. Successful conjugation will only be 
proven when it is demonstrated that the HRP-pAb solution contains a high 
enough concentration of species to retain both antibody and enzyme activity. 
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Figure 16: Size exclusion chromatogram comparing pAb, HRP and HRP-pAb. 
4.2 Transfer-Pipette Column Bead and Conjugate Test  
Tentagel™ Macrobeads were coated with progesterone-3CMO using Bead 
Coating Method 1 (Section 3.3.4.1). The aim of this trial was to confirm 
successful bead coating and successful conjugation in a single experiment using 
the transfer-pipette column (Section 3.3.5.1). It involved rinsing coated beads 
with PBS, exposing the beads to HRP-pAb, rinsing the beads again, and 
exposing them to TMB. The intensity of blue in the eluant from TMB was 
visually evaluated. If there was good binding of HRP or HRP-pAb to the 
column, there would be good contact between TMB and HRP or HRP-pAb, 
and the eluant would be an intense blue. Two concentrations of HRP-pAb 
were tested (1:10,000 and 1:100 dilutions). A control with HRP instead of 
HRP-pAb would show that binding was due to specific antibody-antigen 
interaction and not HRP adsorption to the bead surface. 
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No colour change was observed with the HRP control or the 1:10,000 HRP-
pAb. When substrate was applied after the 1:100 HRP-pAb, the solution in the 
upper glass wool turned blue but the solution in the beads turned a pale 
almond colour. When the TMB in the upper glass wool layer was flushed with 
PBS, it turned from blue to pale almond. 
A very high HRP-pAb concentration (1:100) was needed to give an observable 
colour change. HRP-pAb appeared to be retained in the upper glass wool layer 
as well as in the beads, suggesting either minimal antibody and/or enzyme 
activity in the HRP-pAb or that any progesterone coated on the beads is not 
accessible or not sufficiently populated. 
Most of the applied solution passes straight through the column minimising 
the incubation time, which may affect HRP-pAb binding. Beads suspended in 
a test tube could be incubated for the time required. The disadvantage of this 
method is that it is more difficult to remove the solution without removing the 
beads. 
The TMB reaction appeared to be ‘stopped’ by the beads, which may happen if 
the reaction is pH dependent. The TMB solution was pH 5 while PBS was pH 
7. When TMB solution was applied to the column, it remained at pH 5 in the 
upper glass wool layer (from which most of the PBS had drained) and reacted 
with any HRP or HRP-pAb to turn blue. When the solution drained into the 
bead region, there was sufficient PBS to raise the pH and the TMB turned 
amber rather than blue. The effect of pH on the TMB reaction needs to be 
investigated. 
4.3 pH and Concentration of TMB Reaction 
The aim of this trial was to determine whether pH or concentration affects the 
TMB reaction. The trial involved mixing 0.5 mL of 1:100 (or 1:10000) HRP-
pAb with 0.5 mL of PBS (pH 7.0) (or phosphate-citrate buffer (pH 5.0), or no 
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buffer), then adding three drops (or 0.5 mL) of TMB solution. The colour 
change was observed for each set of conditions. 
Two important characteristics of the HRP-TMB reaction were observed (Table 
7). Firstly, if the HRP-pAb to TMB ratio was too high, the colour changed to 
blue and then quickly to yellow (or almond). This is probably due to blue, 
reacted TMB undergoing a further reaction in the presence of HRP to form a 
yellow final product. When only three drops of TMB solution were added to a 
1:100 HRP-pAb dilution, the reaction proceeded so quickly that the blue 
intermediate product was not observed. However, when 0.5 mL of TMB 
solution was added to a 1:10,000 HRP-pAb dilution, the reaction proceeded 
very slowly. In a plate ELISA assay (and probably in the proposed column of 
beads assay system), enzyme is held on the plate wall (or bead surface) and is 
less accessible and in relatively low concentrations. Therefore, only the blue 
change is observed. 
Secondly, the TMB reaction is pH dependent. At pH 5, the final product is 
yellow but at pH 7 the final product is almond. This is a secondary issue 
because the intermediate product appears the same at both pH 5 and pH 7. 
However, it is recommended that the beads are rinsed with pH 5 buffer before 
the TMB solution is added to ensure a uniform pH throughout the system. An 
alternative might be to prepare TMB at pH 7. This would require less rinsing 
and one less buffer solution - an advantage for an on-line sensor. However, 
this is an unnecessary deviation from the previous developed ELISA procedure 
(Orchard, 2004) and from literature upon which the ELISA was based. 
Improvements could be investigated later when the column of beads assay 
system is proven. 
Data from this trial can explain the results of the previous trial (Section 4.2). 
The upper glass wool layer contained only a small amount of residual HRP-
pAb or HRP so the TMB turned blue. The beads retained a large amount of 
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HRP-pAb or HRP (whether by non-specific binding or antibody-antigen 
interaction) and were at pH 7 so the TMB turned almond. 
Table 7: Effect of HRP-pAb and TMB concentration and pH on colour formation. 
HRP-pAb Buffer TMB Colour 
0.5 mL PBS (pH 7) 3 drops Almond 
0.5 mL citrate (pH 5) 3 drops Yellow 
- 3 drops Blue → Yellow 
0.5 mL 
1:100 
- 0.5 mL Blue → Yellow 
0.5 mL PBS (pH 7) 0.5 mL Blue → Almond (slow) 
0.5 mL citrate (pH 5) 0.5 mL Blue → Green → Yellow (slow) 
0.5 mL 
1:10,000 
- 0.5 mL Blue → Green → Yellow (slow) 
4.4 Test-tube Bead and Conjugate Test I 
The aim of this trial was to confirm successful bead coating and successful 
conjugation in a single experiment, using the batch test-tube setup. The beads 
were removed from the transfer-pipette column, placed in a 10-mL test-tube 
(Section 3.3.5.2) and regenerated with two 5-mL rinses of Regenerant 1. To 
confirm successful regeneration, a development step was completed before 
adding HRP-pAb or HRP. TMB was exposed to the beads, and the optical 
density at 630 nm measured. To test the level of NSB, 1:10,000 unconjugated 
HRP solution (approx. 0.1 μg/mL) with 1% BSA in PBS was stirred for 10 min 
with the beads. A concurrent control tube contained no beads. The amount of 
bound HRP was tested by rinsing with phosphate-citrate buffer (pH 5.0), 
exposing to TMB and measuring the optical density at 630 nm. Beads were 
regenerated as above. To test the level of HRP-pAb binding, the process was 
repeated with 1:10,000 HRP-pAb with 1% BSA in PBS. 
There was no measurable colour change in any of the conditions used in this 
experiment (Table 8) and there are several possible reasons for this. The strong 
regeneration solution (5M NaOH) may have damaged the coating on the beads 
and prevented HRP-pAb binding; the coating may have been minimal in the 
first place; the HRP-pAb concentration may have been too low to elicit a 
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Table 8: Effect of reaction conditions on comparative TMB colour-change with beads exposed to HRP-pAb or HRP in a test-tube. 
Data are optical density from the plate reader. Note: due to differences in the development step, values can not necessarily be compared between experiments. 
Beads 
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x
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t
 
Key Differences in Method Test 
C
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A
*
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e
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Regeneration 0.032 - - - - 
HRP  0.033 - - - 0.034 
4.4 1:10,000 HRP-pAb; strong regen.; beads not blocked; BSA in HRP-pAb soln. 
HRP-pAb 0.037 - - - 0.034 
Regeneration 0.038 - - - - 
HRP-pAb 0.932 - - - - 
4.5 1:100 HRP-pAb; mild regen.; beads not blocked; BSA in HRP-pAb soln. 
HRP 0.274 - - - - 
Regeneration 0.045 - - 0.034 - 4.6 1:100 HRP-pAb; mild regen.; beads not blocked; BSA in HRP-pAb soln. 
HRP-pAb 0.734 - - 0.541 - 
4.7 1:100 HRP-pAb; mild regen.; beads blocked with BSA; BSA in HRP-pAb soln. HRP-pAb 0.458 - - 0.158 - 
4.8 1:100 HRP-pAb; mild regen.; beads blocked with BSA; BSA in HRP-pAb soln. HRP-pAb 0.262 0.049 - - - 
4.9 1:100 HRP-pAb; mild regen.; beads blocked with BSA; no BSA in HRP-pAb soln. HRP-pAb 1.233 - 0.372 - - 
Regeneration 0.052 - 0.035 0.036 - 
HRP-pAb 1.915 - 1.006 1.496 - 
4.10 1:100 HRP-pAb; mild regen.; beads blocked with BSA; no BSA in HRP-pAb soln.; 
extra rinse with pH 5 buffer before 2nd development. 
After buffer 
rinse 
0.514 - 0.187 0.352 - 
* A, B and C denote batches of beads, all coated using Bead Coating Method 1 (Section 3.3.4.1), but prepared at different times. A: earliest, C: latest. 
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meaningful response; the conjugation may have been unsuccessful; or the 
HRP-pAb may have lost either antibody or enzyme activity. 
The next trial was done using higher HRP-pAb concentrations and milder 
regeneration solutions. If it failed, a new batch of beads would be needed to 
eliminate the possibility that the strong regeneration solution had stripped the 
binding sites. 
4.5 Test-tube Bead and Conjugate Test II 
The aim of this trial was to confirm successful bead coating and successful 
conjugation in a single experiment, using the batch test-tube setup. The same 
method as described in Section 4.4 was used with the following exceptions: 
• Regeneration involved four 5-min rinses with the milder Regenerant 2. 
• The HRP-pAb was run prior to the HRP (i.e. the order was reversed). 
• The HRP-pAb and HRP dilution was 1:100 with 1% BSA in PBS. 
• No control tubes were used. 
The results (Table 8) suggest there is good differentiation between the HRP-
pAb (0.932) and HRP (0.274), confirming HRP-pAb antibody and enzyme 
activity and successful bead coating. However, concentrations of stock 
solutions of the two proteins are only approximate and there is no certainty 
that their enzyme activities were equivalent prior to exposure. Therefore, not 
including control tubes with no beads or uncoated beads was a major oversight 
in this trial. It is possible that the observed response was because free protein 
had not been properly rinsed between the binding and development steps or 
because protein was non-specifically bound to the beads. 
A better control would be to test uncoated and coated beads concurrently, thus 
eliminating the need to run HRP. The uncoated beads would indicate NSB or 
the presence of free-protein. 
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4.6 Test-tube Bead and Conjugate Test III 
The aim of this trial was to confirm successful bead coating and successful 
conjugation in a single experiment, using the batch test-tube setup. The 
method described in Section 4.5 was used, but the control was changed. 
Instead of applying unconjugated HRP to coated beads to measure NSB, the 
HRP-pAb was applied to uncoated beads in parallel with coated beads. 
The response with uncoated beads (0.541) was relatively high compared with 
coated beads (0.734), indicating a large amount of NSB (Table 8). To reduce 
NSB, the bead surface could be blocked with BSA. 
4.7 Test-tube Bead and Conjugate Test IV 
The aim of this trial was to confirm successful bead coating and conjugation in 
a single experiment, using the batch test-tube setup. The method described in 
Section 4.6 was used except beads were blocked prior to the binding step by 
exposing them to 2 mL 2% BSA in tris buffer (pH 8.2) for 1 h with stirring. 
Blocking reduced the response with uncoated beads (0.158 cf. 0.541 in Section 
4.6), indicating that NSB was much reduced (Table 8). A similar trend was 
evident with coated beads (0.458 cf. 0.734 in Section 4.6), indicating there was 
a significant amount of NSB here too. The response with uncoated beads after 
blocking was still significant (0.158), indicating that NSB was still a factor. The 
response after blocking was clearly higher on coated than on uncoated beads, 
indicating the system is valid – the bead coating has been successful and the 
HRP-pAb has retained both antibody and enzyme activity. 
However, one flaw in this experiment casts some doubt on this conclusion. 
The uncoated control beads had not had the same wear and tear as the coated 
beads. The coated beads had a longer life and had also been repeatedly exposed 
to 5 M NaOH during the early experiments. These effects may increase the 
NSB capacity of the beads. This hypothesis gains further weight because the 
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HRP-pAb concentration is much higher than that used in the previously 
developed plate ELISA (Orchard, 2004). It may be that we only see a response 
(due to NSB) because the HRP-pAb concentration is so high. 
4.8 Test-tube Bead and Conjugate Test V 
The aim of this trial was to confirm successful bead coating and successful 
conjugation in a single experiment, using the batch test-tube setup. To 
eliminate the possibility that the response was due to NSB, fresh beads were 
coated using Bead Coating Method 1 (Section 3.3.4.1). The experimental 
method described in Section 4.7 was used with the following exceptions: 
• Old coated beads (A) were tested alongside freshly coated beads (B). 
• No uncoated control beads were tested. 
• Blocking was for 30 min rather than 60 min. 
• The HRP-pAb solution contained 1% BSA to help reduce NSB. 
• Phosphate-citrate buffer rinsing between the binding and development 
steps was more thorough, comprising three 5-min exposures with agitation. 
This would ensure that any free HRP-pAb was removed. 
The response with the fresh beads was much lower (0.049) than with old beads 
(0.262), indicating that either the fresh beads were not properly coated or that 
the system is not valid and the old beads had higher NSB due to wear and tear. 
The absolute response cannot necessarily be compared with earlier 
experiments (see Table 8) because the HRP-pAb solution contained 1% BSA. 
The EDC and NHS, coupling agents used in coating the beads are susceptible to 
hydrolysis in the presence of atmospheric water. If the coating failed, it may be 
because the EDC and/or NHS used in the preparation had degraded. 
4.9 Test-tube Bead and Conjugate Test VI 
The aim of this trial was to confirm successful bead coating and successful 
conjugation in a single experiment, using the batch test-tube setup. A fresh 
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batch of beads was prepared using Bead Coating Method 1 (Section 3.3.4.1) 
with freshly purchased and carefully aliquoted EDC and NHS which had been 
stored under the conditions described in Section 3.1.5.1. The method described 
in Section 4.8 was used with the following exceptions: 
• The original coated beads and freshly coated beads were used. The fresh 
beads from Section 4.8 were not used. 
• Blocking was for 1 h. 
• The HRP-pAb solution contained no BSA. 
There was a measurable response with freshly coated beads (0.372) giving hope 
that the coating was successful (Table 8). However, the response ratio between 
the old (1.233) and new (0.372) beads was large (ratio 3.3) and not much better 
than the previous trial in Section 4.8 (ratio 5.3). The large discrepancy between 
old and new beads is most likely from NSB, which is presumed greater in the 
old beads because of additional wear and tear and exposure to harsh chemicals. 
The increase in response from Section 4.8 is probably from NSB, because BSA 
had been omitted from the HRP-pAb solution. This possibility would be 
eliminated if uncoated beads were run as a control. 
4.10 Test-tube Bead and Conjugate Test VII 
The aim of this trial was to confirm successful bead coating and successful 
conjugation in a single experiment, using the batch test-tube setup. The 
method described in Section 4.9 was used with the following exceptions: 
• The uncoated beads from Section 4.9 were used in addition to the original 
(A) and freshly coated (C) beads from Section 4.9. 
• Blocking was for 95 min. 
• After the development and reading steps, beads were rinsed with 
phosphate-citrate buffer (pH 5.0) five times, and additional development 
and reading steps were completed. The intention was to investigate 
whether beads were being rinsed properly. 
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The response with uncoated beads (1.496) was higher than for freshly coated 
beads (1.006), which is opposite to what would be expected if coating was 
successful (Table 8). The most likely reason is that NSB is the dominant 
binding effect. One way to test whether the observed response was due to NSB 
would be to try to inhibit binding with progesterone. If progesterone inhibits 
the response, then some antibody-antigen binding is probably occurring. 
The response appeared to increase with age of the beads. The original coated 
beads (A) were oldest (two months old) and gave the highest response (1.915), 
while the freshly coated beads (C) were newest and gave the lowest response 
(1.006). This supports the hypothesis that bead wear and tear increases NSB.  
Extra rinsing markedly reduced the response for all beads. For example, the 
response with freshly-coated beads decreased from 1.006 to 0.187, indicating 
that rinsing before development was not satisfactory and free HRP remaining 
in solution contributed to the response. Alternatively, weak NSB may be 
washed off with extra rinsing. This result emphasises the need to eliminate 
non-specific response from measurements. A more thorough rinse was 
required. 
4.11 Test-tube Bead and Conjugate Inhibition Test I 
The aim of this trial was to determine whether the observed response was due 
to non-specific or antibody-antigen binding. The experiment was carried out 
with the original coated beads (A) and uncoated beads (A). The stock HRP-
pAb solution contained approximately 1.03 mg/mL, which corresponds to 6.87 
nmol/mL pAb (including both conjugated and unconjugated pAb), or 13.7 
nmol/mL binding sites (two binding sites per molecule). A 1:100 dilution will 
contain 0.137 nmol/mL binding sites. A 1.27 nmol/mL (400 ng/mL) solution of 
progesterone has approximately a 9-fold molar excess over the 1:100 dilution 
of pAb, and should therefore strongly inhibit the antibody-antigen interaction. 
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1. For uninhibited HRP-pAb, a 1:100 dilution was made using PBS as the 
diluent. For inhibited HRP-pAb, a 1:100 dilution was made using 400 
ng/mL progesterone in PBS as the diluent. No BSA was included. The 
solutions were stored in glass test-tubes in a refrigerator overnight. 
2. The beads were regenerated, rinsed and then blocked with 2% BSA for 90 
min.  
3. The uninhibited HRP-pAb was exposed to the beads for 15 min with 
agitation. 
4. The degree of HRP-pAb binding to the beads was measured by exposing 
TMB to the beads and measuring the optical density at 630 nm. 
5. Steps 2-5 were repeated for the inhibited HRP-pAb. 
Data from the first two inhibition tests (sections 4.11 and 4.12) show that 
inhibited HRP-pAb (1.612) gave a stronger response than uninhibited HRP-
pAb (1.191) (Table 9), which was opposite to what would be expected if the 
antibody-antigen interaction were the primary binding effect. This appears to 
confirm that NSB is the dominant effect. 
Coated beads gave a higher response than uncoated beads with both inhibited 
(0.780) and uninhibited (0.885) HRP-pAb. This supports earlier observations 
and reinforces the hypothesis that beads become more susceptible to NSB as 
they age. The response with uncoated beads steadily increased throughout the 
different experiments. 
Non-specific binding appears to be a problem with a 1:100 dilution, which is a 
high concentration compared with the 1:10,000 used for the progesterone-
HRP conjugate in the previously developed ELISA (Orchard, 2004). A 1:100 
dilution is comparable with the 10 μg/mL mAb1 coating concentration used in 
the ELISA. The high level of non-specific response may be because the 
concentration is much higher than if the system were optimum. 
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Table 9: Summary of results from Test-tube Bead and Conjugate Inhibition Tests. 
Data are optical density values from the plate reader. Note: due to differences in the 
development step, data cannot necessarily be compared between experiments. 
Beads 
Ex
pe
ri
m
en
t 
Key Differences in Method Condition 
Co
at
ed
 A
* 
Co
at
ed
 D
* 
U
nc
oa
te
d 
A
** 
U
nc
oa
te
d 
B*
* 
Uninhibited 1.191 - 0.885 - 
4.11
1:100 HRP-pAb; beads blocked 
with BSA; soln. Inhibited 
with P4 
1.612 - 0.780 - 
4.12
1:1000 HRP-pAb; mild regen. 
soln.; beads strongly blocked 
with BSA; extra rinses with pH 
5 buffer before development. 
Uninhibited - 0.047 - 0.050 
* A and D denote batches of beads prepared at different times with different methods. A: original beads 
prepared using Bead Coating Method 1 (Section 3.3.4.1); D: fresh beads prepared using Bead Coating 
Method 2 (Section 3.3.4.2). 
** A and B denote batches of beads prepared at different times with different methods. A: original 
uncoated beads with no special preparation; B: fresh beads prepared using Bead Coating Method 2 
without the coupling agents. 
4.12 Test-tube Bead and Conjugate Inhibition Test II 
The aim of this trial was to determine whether the observed response was due 
to non-specific or antibody-antigen binding. Fresh coated beads (D) were 
prepared using Bead Coating Method 2 (Section 3.3.4.2), recommended by the 
bead supplier. Uncoated beads (B) were prepared simultaneously using the 
same procedure, but omitting the activation reagents and the P4-3CMO. This 
compared coated and uncoated beads, eliminating the effect of bead age. 
The method described in Section 4.11 was used with the following exceptions 
designed to minimise the non-specific response: 
• Blocking was more thorough: 4% BSA was used for 2 h. 
• A lower HRP-pAb concentration was used: 1:1000 dilution. 
• Rinsing was more thorough after the binding step. Beads were rinsed with 
two changes of phosphate-citrate buffer (pH 5.0), followed by 5 min of 
agitation. This was repeated twice more before adding TMB. 
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The experiment was stopped after uninhibited HRP-pAb did not respond with 
either coated (0.047) or uncoated (0.050) beads (Table 9). The negligible 
response for both beads indicates that measures taken to minimise the non-
specific response were effective.  
We also concluded that either conjugation was not effective in combining pAb 
and HRP activity into a single species, or that the coating was not successful in 
providing an antigen surface capable of interacting with pAb or HRP-pAb. The 
inability to obtain a clear conclusion highlights a major flaw in the experiment 
- trying to validate both components of the system at the same time. Later 
experiments aimed to validate either the conjugation or the bead coating. 
4.13 Microtitre Plate Conjugate Test I 
A microtitre plate assay was used to confirm the binding activity of HRP-pAb. 
This method is based on a successful ELISA (Orchard, 2004) and involved 
mixing HRP-pAb with a progesterone-HRP conjugate (P4-HRP) to prevent 
P4-HRP from binding to the antibody surface. The P4-HRP was conjugated at 
the 3-carbon (the same as the bead coating). If HRP-pAb interacts with P4-
HRP, then it is also likely to interact with the bead surface. 
1. Wells were coated with mAb1, by placing 100 μL of 10 μg/mL mAb1 in the 
wells for 2 h. 
2. After washing (with ELISA plate wash solution: Appendix A-1.6), wells 
were blocked with 200 μL of 2% BSA for 1 h. 
3. Test solutions were prepared (5 mL each):  
a. 1:500 dilution of HRP-pAb in PBS with 1% BSA. 
b. Positive control: 2 μg/mL pAb in PBS with 1% BSA. 
c. Negative control: PBS with 1% BSA. 
4. 12.5 μL 1:200 P4-HRP was added to each test solution to give a final P4-
HRP dilution of 1:80,000. The pAb component of test solutions ‘a’ and ‘b’ is 
far in excess of this concentration and so should strongly inhibit P4-HRP 
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binding to the mAb1 surface of the well. The mixtures were incubated for 
15 min at room temperature. 
5. After washing the wells, 100 μL of the mixture was placed in the wells and 
incubated for 1 h with agitation. 
6. After washing again, 100 μL of TMB solution was placed in the wells and 
allowed to develop. The plate was read at 630 nm after about 10 min. 
Unfortunately, the plate reader malfunctioned so numerical values could not 
be obtained. A photograph of the plate (Figure 17) shows a strong colour 
change in all wells. There is no discernible difference between wells, 
indicating that neither HRP-pAb nor pAb inhibited P4-HRP. The mixture may 
not have been incubated long enough before being placed in the wells as some 
inhibition is expected. Otherwise, it would be concluded that pAb does not 
interact with P4-HRP, which would explain why the HRP-pAb, conjugated at 
the same location, would not bind to the beads. mAb1 from UC Davis (CL425) 
was raised against progesterone-11α-hemisuccinyl-BSA, which earlier ELISA 
work showed interacted with P4-HRP (Orchard, 2004). pAb was similarly 
raised against progesterone-11α-BSA, so we would expect the two antibodies 
to have similar activity towards the antigen. 
 
A         B         C         D         E         F         G         H 
Figure 17: ELISA plate from Microtitre Plate Conjugate Test I.  
Wells E, F and H were HRP-pAb, C and D were the positive control (pAb), and A, B 
and G were the negative control. 
4.14 Microtitre Plate Conjugate Test II 
This trial compared the binding activity of HRP-pAb, pAb and mAb1. The 
method described in Section 4.13 was used except mAb1 was included. The 
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mAb1 solution was made fresh and the other three samples were retained from 
Section 4.13. 
Data from the first five Microtitre Plate Conjugate Tests (sections 4.13-4.17) 
are summarised in Table 10. Free mAb1, which is known to interact with P4-
HRP, failed to inhibit interaction with the immobilised mAb1 (response 1.018) 
compared to the control (0.997). Therefore, no conclusions can be drawn from 
this or the previous experiment (sections 4.13). 
The P4-HRP may favour the immobilised mAb1 over the free mAb1, pAb or 
HRP-pAb. Perhaps P4-HRP is effectively removed from solution when it is 
bound to the immobilised mAb1. Given that bound and unbound states of P4-
HRP will be in equilibrium, the long incubation time for binding may allow 
most of the P4-HRP to be ‘removed’ from solution by being bound to the 
surface. This could be tested by reducing binding time. 
Table 10: Summary of results from the Microtitre Plate Conjugate Tests  
In these experiments, the plate surface was coated with mAb1 and an Ab-based 
inhibition agent was used to inhibit binding of P4-HRP to the surface. Each value is 
the average of two replicates. Note: due to differences in the development step the 
values cannot necessarily be compared between experiments. 
Inhibition Agent 
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4.13 Binding 60 min High High High - - - 
4.14 Binding 60 min 0.997 1.015 1.016 - - 1.018 
4.15 Binding 10 min 0.467 0.211 0.433 - - 0.288 
4.16 Binding 10 min 0.376 0.338 0.389 - 0.065 - 
4.17
Binding 10 min; fresh 
prep’d HRP-pAb 
0.124 0.154 0.149 0.183 - - 
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4.15 Microtitre Plate Conjugate Test III 
This trial compared the binding activity of HRP-pAb, pAb and mAb1. The 
previous method (Section 4.14) was used except binding time was reduced 
from 1 h to 10 min. 
mAb1 (0.288) and pAb (0.211) both had lower responses than the control 
(0.467), indicating they both inhibit P4-HRP (Table 10). It appears that both 
antibodies were active to progesterone conjugated at the 3-carbon. 
HRP-pAb (0.433) had a similar response to the control (0.467), indicating it did 
not inhibit P4-HRP. Antibody activity appeared to be lost during conjugation 
and/or subsequent storage. HRP-pAb was stored for several weeks at fridge 
temperature, which may have contributed to loss of activity.  
An alternative, but less likely, explanation for the higher response with HRP-
pAb is that it, or free unconjugated HRP in the conjugate solution, non-
specifically bound to the surface and interacted with the TMB, causing a 
colour change.  
4.16 Microtitre Plate Conjugate Test IV 
This trial compared the binding activity of HRP-pAb and pAb. The method 
described in Section 4.15 was used except an extra HRP-pAb sample with no 
P4-HRP was included instead of mAb1. This would indicate whether NSB of 
the HRP-pAb to the surface was occurring. All protein solutions were 
prepared fresh from the freezer. 
Although the pAb response (0.338) was lower than the control (0.376), the 
difference was much smaller than in Section 4.15, suggesting that antibody 
binding ability is not as strong as originally thought (Table 10). The HRP-pAb 
response (0.389) was very similar to the control (0.376), confirming that HRP-
pAb has no antibody activity. The ‘no P4-HRP’ sample had negligible response 
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(0.065), confirming that the HRP-pAb response was not due to NSB to the 
plate. 
4.17 Microtitre Plate Conjugate Test V 
This trial compared the binding activity of HRP-pAb and pAb. The method 
described in Section 4.16 was used with the following exceptions: 
• Freshly conjugated HRP-pAb was used. 
• The no P4-HRP control was omitted. 
• Two concentrations of HRP-pAb were used: 1:100 and 1:500. 
Unexpectedly, the responses of all test solutions, pAb, 1:500 HRP-pAb and 
1:100 HRP-pAb were higher (0.154, 0.183 and 0.149 respectively) than the 
control (0.124) (Table 10). The control had no antibody, and should therefore 
not inhibit P4-HRP and give the highest response. 
The response of the 1:100 HRP-pAb was higher than the 1:500 HRP-pAb, 
which was also unexpected. The 1:100 has more antibody and should therefore 
inhibit P4-HRP more and give a lower response than the 1:500 dilution. 
These results contradict results from Section 4.15, which demonstrated pAb 
had antibody activity. In this experiment (as for Section 4.16), antibody 
activity was questioned. One possible explanation for pAb having low activity 
may be that the antigen used to purify the pAb was coupled at a different 
location on the molecule than the antigen used for mAb1. 
Based on the uncertain activity of pAb for progesterone coupled at the 3-
carbon, it was decided to use mAb1 for conjugation, which is known to 
interact with progesterone coupled at the 3-carbon. Using this antibody 
removes one source of uncertainty about the system. The pAb probably has the 
advantage of being commercially available in larger quantities, but that 
currently is a low priority. The first priority is to develop a suitable sensor 
system before beginning to think about commercial considerations. 
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4.18 ELISA mAb1 and pAb Comparison 
This trial used a simple plate ELISA to compare the activity of the two 
antibodies by coating them directly onto the well (by adsorption), exposing the 
surface to P4-HRP and developing with TMB solution. 
1. A 10 μg/mL solution of each antibody was prepared in carbonate buffer 
(pH 9.6). 
2. A fresh plate was opened and column A was coated by incubating for 2 h 
with 100 μL mAb1 in each well. Column B had pAb. 
3. The wells were rinsed with wash solution (Appendix A-1.6). All the wells 
were blocked by incubating for 1 h with 150 μL 1% BSA. 
4. The wells were rinsed again and antibody activity was tested by incubating 
for 10 min with 100 μL 1:80,000 P4-HRP with agitation. 
5. Wells were rinsed again and P4-HRP bound to the antibody surface was 
detected by developing with TMB solution for 5 min with agitation. 
None of the wells changed colour, indicating that neither the pAb nor mAb1 
bound P4-HRP significantly. As mAb1 was known to interact with P4-HRP, 
the experiment is flawed. This result was attributed to using the same P4-HRP 
concentration (1:80,000 dilution) as the ELISA (Orchard, 2004) but using a 
binding time of only 10 min instead of 1 h. 
No more comparisons were possible because the supply of pAb had been 
exhausted. To eliminate doubt about the antibody-antigen interaction, mAb1 
with a known interaction with progesterone coupled at the 3-carbon was used 
in all further trials. 
4.19 SPR Surface and Antibody Activity Test I 
The aim of this trial was to confirm that there was interaction between an SPR 
surface coated with progesterone and mAb1. Previous attempts to confirm 
successful conjugation or coating had been somewhat clumsy. Too many new 
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parameters and techniques were tested at once so the causes of problems that 
arose were not clear. 
The microtitre plate experiments attempted to overcome this by using 
established technology to measure antibody activity. If antibody activity could 
be measured, the bead coating could be tested by its ability to bind antibody. 
The plate system is designed to measure progesterone concentration by 
competitive assay against P4-HRP rather than to measure antibody activity. 
Data from attempts to measure and compare antibody activity by P4-HRP 
inhibition were poor, so this line of testing was abandoned in favour of the 
SPR method. 
The Biacore SPR system is based on established technology and there are at 
least two reports of Biacore SPR-based progesterone assays (Gillis et al., 2002; 
Wu et al., 2002). The system has many advantages over the plate system: 
• It measures antibody activity directly. 
• Antigen is bound to the chip surface in exactly the same way as to beads so 
the chip will imitate the bead surface and give a relevant measure of 
activity. 
• Binding events can be viewed in real-time rather than as a single reading at 
the end of the assay. 
• It is automated, so is probably more repeatable. 
The chip was coated with P4-3CMO using the method described in Section 
3.3.1.1. Two antibody samples were used to test the surface: mAb1 and mAb2. 
Because stocks of pAb, which was used in the initial conjugation and test-tube 
bead experiments, had been exhausted, it was not tested. 
This was the first time the chip had been used after coating so six regeneration 
cycles (Section 3.3.1.3) were run to ensure the surface was stable. Regenerant 2 
was used for the regeneration cycles and the test routine. Each antibody was 
diluted to 10 μg/mL in PBS and tested in duplicate by SPR using Test Routine 1 
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(Section 3.3.1.2). This initial concentration was selected because it was used in 
the previously developed ELISA (Orchard, 2004). 
There was a strong response with mAb1 and mAb2 (2731 and 2439 RU 
respectively). As the antigen on the surface is the same as that to be 
immobilised on the beads, this important result implies that mAb1 and mAb2 
should also interact strongly with the active surface of the beads. 
4.20 Conjugate Antibody Activity Test  
The aim of this trial was to confirm that (a) there is an interaction between the 
SPR surface coated with progesterone and HRP-pAb and (b) that this 
interaction is inhibited by free progesterone. 
A new batch of conjugate was prepared using mAb2 using the conjugation 
method described in Section 3.3.2. To confirm that the conjugated mAb2 
(HRP-mAb2) had retained activity, it was diluted to an equivalent mAb2 
concentration of 10 μg/mL and tested by SPR. Control solutions of 10 μg/mL 
BSA, HRP and unconjugated mAb2 were also tested. Separate mAb2 and HRP-
mAb2 samples were also spiked with progesterone to test for inhibition by 
adding 200 μL 400 ng/mL progesterone in PBS to 1000 μL of the original 10 
μg/mL solution. This amount of progesterone is far in excess of the available 
antibody binding sites, so there should be strong inhibition. Control solutions 
were prepared in the same way using 200 μL PBS instead of progesterone. All 
samples were tested by SPR using Test Routine 1. 
If HRP conjugates to mAb2, then each molecule would give a larger SPR 
response than an unconjugated mAb2 molecule. Therefore, assuming antibody 
activity is not lost during conjugation, the HRP-mAb2 response should be 
larger than the mAb2.  
mAb2 (1738.8 RU) and HRP-mAb2 (1748.5 RU) had similar responses (Table 
11), which could either mean that there was little conjugation, or that loss of 
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antibody activity during conjugation cancelled out the increased response per 
bound molecule. Further testing is required to clarify which is most likely. 
Samples spiked with progesterone gave a much smaller response than those 
spiked with buffer, indicating (as expected) that free progesterone inhibits the 
SPR response. 
Table 11: Summary of results from the Conjugate Antibody Activity Test. 
Sample SPR response* (RU) Sample SPR response* (RU) 
mAb2 1738.8 BSA -29.4 
HRP-mAb2 1748.5 HRP -50.8 
mAb2 + PBS 1027.1 mAb2 + P4 60.9 
HRP-mAb2 + PBS 1147.3 HRP-mAb2 + P4 72.9 
* n=2 
4.21 SDS-PAGE Conjugation Evaluation 
This trial evaluated the success of conjugation using the SDS-PAGE method 
described in Section 3.3.3. mAb2, HRP and HRP-mAb2 were tested. 
Unfortunately a reducing buffer was used, so the mAb2 was cleaved. The 
cleaved mAb2 bands were visible at about 25 and 45 kDa and the HRP band 
was visible at 40 kDa (Figure 18). These bands were also visible in the HRP-
mAb2 columns, indicating conjugation was incomplete. 
The HRP-mAb2 columns had a smear extending from approximately 45 to 200 
kDa, which was probably conjugated material. This may be due to cleaving. If 
the HRP-mAb2 were not cleaved, we would expect bands at 190, 230, etc. 
kDa, but with cleaving, we expect bands at 65, 85, 105 etc. kDa, and these may 
not be easily resolved (although the faint darker patches in the smear from the 
420 μg/mL HRP-mAb2 column may be bands).  
There was certainly some higher molecular weight material after conjugation, 
which probably includes some HRP-mAb2, but also a significant amount of 
unconjugated material. As discussed in Section 4.1, unconjugated material may 
pose no problem to the performance of the system. The final proof of 
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successful conjugation would be when HRP-mAb2 was bound to immobilised 
antigen and still catalysed the TMB reaction, thus demonstrating that the 
molecules binding to the antigen also have enzyme activity. Using beads would 
be the easiest way to do this but the bead coating needed to be validated first. 
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Figure 18: SDS-PAGE gel comparing mAb2, HRP and HRP-mAb2. 
* heavy chain; ** light chain. 
4.22 Syringe Bead Test I 
This trial was to confirm that the coated bead surface interacted with mAb1. 
New batches of coated and uncoated beads were prepared using Bead Coating 
Method 2 (Section 3.3.4.2). Each set of beads was loaded into a syringe (Section 
3.3.5.3). If the coating was successful, then mAb1 would be extracted from 
solution when exposed to the beads. 
1. The coated and uncoated beads were rinsed five times with PBS to ensure 
the pH at the bead surface was suitable for antibody-antigen interaction. 
Each time fresh PBS was aspirated, the syringe was agitated at 400 rpm for 
2 min. Finally, the plunger was pushed to the 0.5 mL mark, ready to 
aspirate the sample. 
2. 10 μg/mL mAb1 in PBS was aspirated up to the 2 mL mark for both coated 
and uncoated beads. The syringes were agitated at 400 rpm for 10 min. 
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3. The sample was then dispensed from the syringe by pushing the plunger to 
the 0.5-mL mark and collected in a Biacore vial. 
4. The beads were regenerated with three rinses of Regenerant 3, each time 
agitating for 2 min. 
5. Steps 1 to 4 were repeated using the following additional samples: 
a. 10 μg/mL mAb1 with 0.1% BSA. A higher response than the 
sample without BSA may indicate NSB on the bead surface. 
b. 0.1% BSA as a control. 
6. The dispensed samples and control samples not exposed to any beads were 
tested by SPR using Test Routine 1. 
None of the samples gave a response, regardless of whether they had been 
exposed to beads, suggesting that either mAb1 or the SPR chip coating had 
degraded. 
4.23 SPR Surface and Antibody Activity Test II 
The aim of this trial was to reconfirm that there was interaction between the 
SPR surface coated with progesterone and mAb1. The method used in Section 
4.19 was used with the following exceptions: 
• Only mAb1 was used. 
• 1% BSA was included in the sample. 
• A control sample of 1% BSA without mAb1 was included. 
A large response with the 1% BSA control sample (754.1 RU) compared with 
the negligible response observed in the earlier experiment with the 10 μg/mL 
(0.001%) BSA solution (Section 4.19) indicated that BSA interacted non-
specifically with the chip surface and thus, if present in high enough 
concentrations, would interfere with measurement of antibody activity. There 
were three ways to overcome this problem: 
1. Reduce BSA concentration to a level that would still protect mAb1 yet did 
not give a significant SPR response. 
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2. The sensorgram (Figure 19) shows the sensor response due to BSA 
decreasing steadily after sample injection has finished because the BSA was 
being slowly flushed by the running buffer. Extending the running buffer 
period after sample injection so non-specifically bound material was rinsed 
off should leave only strongly-bound mAb1 to be measured. The drawback 
of this modification was that cycle time would increase. 
3. Normally only two of the four channels on a Biacore SPR chip are coated. 
The sample is simultaneously run through coated and uncoated channels 
and the non-specific response for each sample (measured in the uncoated 
channel) is automatically subtracted from the overall response (measured 
in the coated channel) in real time. Unfortunately, due to the coating 
method, the entire surface was coated, so another chip and an alternative 
coating method would be needed. 
Despite the high non-specific response, an antibody-antigen interaction was 
detected. The response for mAb1 with BSA was 1815 RU compared with 754 
RU for BSA only, giving a net response due to antibody of over 1000 RU. 
Although this is lower than in Section 4.19, it is high enough to allow the 
beads to be tested. It seems that the antibody and our surface still interact. 
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Figure 19: SPR sensorgrams for 10 μg/mL mAb1 with 1% BSA and for 1% BSA. 
 73
4.24 Syringe Bead Test II 
This trial examined whether there is NSB of mAb1 to the beads. 
1. The beads in the syringe from Section 4.22 were rinsed three times with 
PBS (minimal agitation each time). 
2. 10 μg/mL mAb1 in PBS (no BSA) was freshly prepared from stock solution, 
aspirated to the 2 mL mark with the uncoated beads and manually agitated 
for 15 min. 
3. The sample was dispensed into a Biacore vial and tested by SPR using Test 
Routine 1. 
4. A sample that had not been exposed to the beads was also tested by SPR. 
5. The beads were regenerated by rinsing three times with Regenerant 3, 
agitating gently for 1 min each time. 
The response for unexposed mAb1 was 463.5 RU (Table 12), which was lower 
than observed in previous experiments. This may be because the mAb1 had 
been out of the freezer for a week, although stability should be better than 
this. 
Table 12: Summary of results from the Syringe Bead Tests. 
mAb1 solution was exposed to beads in the syringe and the dispensed solution 
analysed by SPR (n=2). 
SPR response 
(RU, average of duplicates) 
[mAb1] 
(μg/mL) 
[BSA] 
(%) 
Blocked Beads Experiment 
Co
at
ed
 
Be
ad
s 
U
nc
oa
te
d 
Be
ad
s 
N
o 
Be
ad
s 
10 0 No 4.24 - 43.5 463.5 
10 0 Yes (1% BSA) 4.25 - 113.7 - 
10 0.01 Yes (1% BSA) 4.26/4.27 11.6 127.3 - 
0 0.1 N/A 4.26 - - 49.7 
10 0.01 Yes (2% BSA) 4.28 12.3 211.7 
424.1 
13.2* 
25 0.01 Yes (2% BSA) 4.30 37.0a 51.7b
107.9a
49.4b
* The unexposed control sample was repeated at the end of the experiment. 
a,b Separate batches of solution. 
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The response for mAb1 exposed to uncoated beads was 43.5 RU, which was 
much smaller than for unexposed mAb1 and indicates substantial NSB of 
mAb1 to the beads. Practically all mAb1 was removed from the solution. To 
minimise NSB, the beads could be ‘blocked’ by pre-exposing them to a dummy 
protein such as BSA, or BSA could be included in the mAb1 solution. 
Alternatively, contact time between mAb1 and the beads could be reduced, 
limiting the time for NSB. 
4.25 Syringe Bead Test III 
The aim of this trial was to devise a method to minimise NSB of mAb1 to the 
beads. BSA was used to block the bead and syringe surfaces. 
1. The beads were rinsed five times with PBS (minimal agitation each time). 
2. The beads were blocked by aspirating 1% BSA in PBS to the 2 mL mark 
and agitating gently for 15 min. 
3. The beads were rinsed three times with PBS (minimal agitation each time) 
to remove any unadsorbed BSA, which may interfere with SPR analysis. 
4. 10 μg/mL mAb1 in PBS (no BSA) was prepared from stock solution, 
aspirated to the 2 mL mark with the uncoated beads and manually agitated 
for 15 min. 
5. The sample was dispensed into a vial and tested by SPR. 
6. The beads were regenerated by rinsing three times with Regenerant 3, 
agitating gently for 1 min each time. 
The response for the sample exposed to blocked uncoated beads (113.7 RU) 
was higher than with uncoated beads in Section 4.24 (43.5 RU), suggesting that 
blocking the beads prevented some NSB (Table 12). However, the response 
was still very low and not large enough to be useful. Including BSA in the 
sample solution might further reduce NSB. 
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4.26 Syringe Bead Test IV 
This trial investigated a method to minimise NSB of mAb1 to the beads. BSA 
was used to block the beads and included in the sample solution. The method 
described in Section 4.25 was used except the mAb1 sample contained 0.01% 
BSA. The low BSA concentration minimised the chance of NSB to the SPR 
chip. A 0.1% BSA sample was also tested by SPR to test NSB to the surface at 
this concentration. 
The response for the sample containing 0.01% BSA and exposed to blocked 
uncoated beads was 127.3 RU (Table 12). This is very similar to the response 
obtained in Section 4.25 and indicates that including 0.01% BSA has a 
negligible effect on loss of mAb1. The 0.1% BSA negative control gave a 
response of 49.7 RU. This may have been a non-specific SPR response, albeit 
low, so it was decided to avoid using this concentration if possible. 
4.27 Syringe Bead Test V 
This trial was to determine whether the coated surface of the beads interacted 
with mAb1. The method described in Section 4.26 was used except that coated, 
instead of uncoated, beads were used. Obtaining a much lower response than 
reported in Section 4.26 would indicate that the coating was successful. 
The response for the sample containing 0.01% BSA and exposed to blocked 
coated beads was 11.6 RU. This was much lower than the corresponding result 
of 127.3 RU for uncoated beads (Section 4.26; Table 12) and indicated that 
coating was successful. However, the response for uncoated beads and even for 
mAb1 not exposed to beads (463.5 RU; Section 4.24; Table 12) was small 
compared with earlier values of 1500-2500 RU obtained using the same mAb1 
concentration. The mAb1 was one week old and may have degraded, which 
may explain the lower than expected responses. It was decided to replicate the 
trial using fresh mAb1 that gives a strong response. 
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The NSB of mAb1 to the beads appeared to be a significant problem. Beads of a 
different material may have lower NSB. 
4.28 Syringe Bead Test VI 
This trial investigated whether the coated surface of the beads interacted with 
mAb1. The method described in Section 4.26 was used with the following 
exceptions: 
• To further reduce the chance of NSB, a higher blocking BSA concentration 
of 2% was used and the time the sample was in contact with the beads was 
reduced from 15 min to a single inversion. 
• Both coated and uncoated beads were used. A sample that had not been 
exposed to the beads was also tested by SPR, both before and after samples 
that were exposed. 
The initial results (Table 12) were promising. The mAb1 sample exposed to 
uncoated beads had a lower response (211.7 RU) than initial samples that had 
not been exposed to beads (424.1 RU), indicating some degree of NSB. The 
sample exposed to coated beads gave a negligible response (12.3 RU), 
indicating that the coating was successful. 
However, final retesting of the sample not exposed to beads also gave a 
negligible response (13.2 RU). All results obtained in this experiment could be 
explained as being due to antibody degradation, and this raises doubt about the 
stability of mAb1. The rapid degradation was very surprising because mAb1 
had been taken from the freezer and thawed on the day of this experiment. 
4.29 Antibody Stability Test I (temperature and dilution) 
This trial examined the stability of mAb1 at different concentrations and 
stored at different temperatures for various times. 
1. 2 mL of 252.5 μg/mL mAb1 was taken from the freezer and thawed. 
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2. Two 1-mL solutions of 10 μg/mL mAb in PBS were prepared, and the 
remaining 252.5 μg/mL solution was divided into two parts. 
3. One sample of each concentration was stored at room temperature and the 
other was stored in a cold box. Temperature of the cold box was monitored 
throughout the experiment and ranged from 3.3 to 6.1°C. 
4. Solutions were tested periodically throughout the day: 
o The dilute, room temperature sample was stored in the Biacore SPR 
system sample-rack inside the instrument and sampled directly by 
the instrument. 
o The dilute, cold sample was stored in the cold box. A 70-μL sub-
sample was taken and transferred to the SPR system for each 
analysis. 
o The non-dilute, room temperature sample was stored on the bench. 
A small sub-sample was diluted with PBS to 10 μg/mL for each 
analysis. 
o The non-dilute, cold sample was stored in the cold box. A small 
sub-sample was diluted with PBS (room temperature) to 10 μg/mL 
for each analysis. 
Although SPR is strongly dependent on temperature in the flow cell, the 
sample temperature should not have affected SPR measurement. The fluid path 
in the Biacore is very narrow and any temperature differences in the samples 
were probably eliminated before they enter the flow cell. 
The results indicate that mAb1 was stable even without using BSA as there was 
no measurable loss of activity for the storage temperatures, times or 
concentrations used in the trial (Figure 20). This level of stability is good 
enough for testing the beads. 
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Figure 20: Changes in SPR response of mAb1 under different temperature and 
concentration storage conditions. 
4.30 Syringe Bead Test VII 
This trial investigated whether the coated surface of the beads interacted with 
mAb1. 
1. Both the coated and uncoated beads were rinsed three times with PBS. 
2. The beads were blocked by aspirating 1% BSA and manually agitating for 
15 min. 
3. The beads were rinsed a further three times with PBS to remove free BSA. 
4. Three batches of 10 μg/mL mAb1 in PBS were prepared. The mAb1 stock 
solution used was the cold non-dilute mAb1 solution from Antibody 
Stability Test I (Section 4.29) the previous day, which had been found to be 
quite stable. 
o Two 2-mL batches had 0.01% BSA to minimise NSB to the beads. 
o One 250-μL batch had no BSA as a control, and was not exposed to 
the beads. 
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5. One of the two batches with BSA was exposed to the uncoated beads while 
the other was exposed to the coated beads. Both samples were exposed for a 
single inversion of the tube and then dispensed into separate vials. 
6. Five vials were tested by SPR: the two dispensed samples; the remainder of 
the two batches with BSA left after aspiration into the syringe; and the 
batch without BSA. 
7. The beads were regenerated by rinsing three times with Regenerant 3, 
agitating gently for 1 min each time. 
8. The beads were rinsed five times with PBS to remove the regenerant. 
The SPR responses for all samples, including those not exposed to the beads, 
were less than 30 RU. All antibody activity had been lost in the 18 h between 
the end of Antibody Stability Test I (Section 4.29) and this experiment. All 
samples from Antibody Stability Test I were retested. Their SPR responses 
were all lower than 73.8 RU, confirming that all samples had lost activity. This 
now confirms a serious antibody stability problem. However, even at this level 
of stability, it should be possible to confirm the success of bead coating with a 
properly-controlled experiment by using fresh mAb1 from the freezer and 
completing the experiment quickly. 
4.31 Syringe Bead Test VIII 
This trial investigated whether the coated surface of the beads interacted with 
mAb1. Two freshly-thawed aliquots of mAb1, diluted to 10 μg/mL, gave 
responses of 301.2 and 137.2 RU when tested by SPR. Both these responses are 
low so a higher concentration was used for the experiment. The method 
described in Section 4.30 was used except mAb1 concentration was 25 μg/mL 
and 2% BSA was used for blocking. A BSA-free control was included. 
The response for the sample exposed to coated beads was lower (37.0) than 
when the sample was not exposed (107.9). There was no difference in response 
for the corresponding samples exposed to uncoated beads (51.7 versus 49.4), 
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indicating that the coated surface may be interacting with mAb1 (Table 12). 
However, due to the low response for all samples, it is not reasonable to draw 
this conclusion. The observed differences are smaller than variations in 
response occasionally observed between theoretically equivalent antibody 
samples. 
Antibody stability in the two freshly-thawed samples used in this experiment 
was much worse than for Antibody Stability Test I (Section 4.29). Within a 
few hours of being removed from the freezer, nearly all activity had been lost. 
It is useful to review the antibody storage procedure (Section 3.1.3). This 
storage procedure was reasonable but not perfect. Proteins are normally most 
stable when concentrated. Diluting the antibody increases its susceptibility to 
several modes of activity-loss (Deutscher, 1990). Furthermore, diluent buffer 
was prepared in glassware used for storing milk for unrelated work so it may 
have been contaminated with microbes with their associated degradative 
enzymes to the antibody. 
Due to these concerns, the storage procedure was modified. A new shipment of 
mAb was received (mAb3) and stored in very small aliquots of the original 
concentrated 10.1 mg/mL solution so it would only be exposed to potentially-
contaminated buffers immediately before use. 
4.32 SPR Surface and Antibody Activity Test III 
This trial investigated whether there was interaction between the SPR surface 
coated with progesterone and the mAb3. Stored in concentrated form (10.1 
μg/mL), mAb3 was first diluted to 202 μg/mL and then to 10 μg/mL in PBS 
before being tested by SPR using Test Routine 1 (Section 3.3.1.2). 
The average SPR response was 1587.7 RU, which is similar to the good 
responses observed in the initial SPR work (Section 4.19). Because of the new 
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storage procedure and the relative freshness of mAb3, there was confidence 
that the bead coating could be tested successfully. 
4.33 Syringe Bead Test IX 
This trial investigated whether the coated surface of the beads interacted with 
mAb3. 
1. The coated and uncoated beads were rinsed three times with PBS. 
2. The beads were blocked by aspirating 2% BSA and manually agitating for 
15 min. 
3. The beads were rinsed three times with PBS. 
4. Two 2-mL samples of 10 μg/mL mAb3, 0.01% BSA in PBS were prepared 
from the same thawed aliquot of mAb3 used in SPR Coating and Antibody 
Activity Test III (Section 4.32) earlier the same day. 
5. A 1.5 mL aliquot from one sample was exposed to the uncoated beads and 
one from the other sample was exposed to the coated beads for a single 
inversion of the tube and then dispensed into separate vials. 
6. The dispensed sub-samples and the un-aspirated samples were tested by 
SPR using Test Routine 1 (Section 3.3.1.2). 
7. The beads were regenerated by rinsing three times with Regenerant 3, 
agitating gently for 1 min each time. 
8. The beads were rinsed five times with PBS to remove the regenerant. 
The SPR response of the control samples was too low (13.7 RU) so no 
conclusion could be made about the bead coating. This experiment was carried 
out within 2 h of the good result that was obtained in SPR Coating and 
Antibody Activity Test III (Section 4.32). Antibody activity had decayed from 
about 1600 to about 10 RU indicating that the antibody stability problem was 
not resolved by using a new shipment of mAb and improving the storage 
procedure. 
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4.34 Modifying SPR Test Routine for 1% BSA I 
This trial investigated whether a SPR test routine with a longer buffer run-
time after sample injection could be developed to sufficiently rinse away non-
specifically bound BSA. One way to protect proteins from degradation is to 
include a high concentration of a ‘dummy’ protein such as BSA, which 
necessitates a change to the test routine. 
The SPR response for samples with 1% BSA, immediately after injection, was 
higher than for samples without BSA (Figure 21) and gradually decreased as 
buffer rinsed away the BSA. 
The total rinse time for Test Routine 1 (Section 3.3.1.2) was 107 s with a flow-
rate of 10 μL/min. The response was measured 30 s before the end of rinsing, 
so the effective rinse time was 77 s. The test routine was modified by 
incrementally increasing the effective rinse time and the rinse flow rate until 
the measured relative response for 1% BSA in PBS was insignificant. After 
defining a suitable test routine, a 10 μg/mL mAb3 sample containing 1% BSA 
was tested by SPR to show that mAb3 was not also rinsed away. 
Improving the rinsing procedure successfully reduced the relative response in 
the absence of mAb3 to insignificant levels (38.8 RU, Figure 21, Table 13). The 
effective rinse time was 427 s with a rinse flow rate of 30 μL/min. 
Table 13: Effect of rinse time and flow rate on relative response with 1% BSA. 
Effective rinse 
duration (s) 
Rinse flow rate 
(μL/min) 
Relative response 
for 1% BSA (RU) 
77 10 745.7 
222 10 140.8 
401 10 71.8 
427 30 38.8 
However, when mAb3 was included in the sample, the response did not return 
to the baseline after regeneration (Figure 22). The response after regeneration 
was 313.5 RU higher than the baseline response before sample injection. 
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Further improvements to the procedure were needed to ensure the surface was 
adequately regenerated and ready for the next sample. 
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Figure 21: SPR sensorgrams with 1% BSA for (a) Test Routine 1 and (b) a modified 
routine with longer rinse time and faster rinse flow-rate. 
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Figure 22: SPR sensorgram for 10 μg/mL mAb3 with 1% BSA using the modified test 
routine with an increased rinse time and increased rinse flow rate. 
4.35 Modifying SPR Test Routine for 1% BSA II 
This trial investigated how to improve the regeneration part of the test routine 
so the response would return to the baseline after injecting mAb3 with 1% 
BSA. During regeneration, the response gradually decreased as the SPR surface 
was cleaned (Figure 22). The duration and flow rate of Regenerant 3 were 
increased incrementally until the response after regeneration when testing 10 
μg/mL mAb3 was insignificant.  
Improvements to the regeneration step successfully regenerated the chip 
surface. The response after regeneration was 97.6 RU lower than the baseline 
before sample injection (Table 14, Figure 23). The final routine (Test routine 2) 
had a regeneration time of 449 s, which is three times longer than Test routine 
1. Regeneration flow-rate did not affect the success of regeneration so it was 
concluded that contact time between the regenerant and the surface was the 
most important factor in regeneration. Now a test routine that could handle 
1% BSA had been developed, solutions containing such high BSA 
concentrations could be used to test the beads.  
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The antibody stability problem was again observed in this trial. The very large 
relative SPR response due to mAb3 (2185.1 RU) had decreased to only 165.9 
RU when tested later in the day.  
Table 14: Effect of modifying the SPR Test Routine to handle 1% BSA. 
Regeneration 
duration (s) 
Regeneraton flow 
rate (μL/min) 
Relative response after 
regeneration for 10 μg/mL 
mAb3, 1% BSA (RU) 
149 10 313.5 
149 30 360.9 
449 10 -97.6 
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Figure 23: SPR sensorgram for 10 μg/mL mAb3 with 1% BSA using Test Routine 2. 
4.36 Antibody Stability Test II (pH) 
This trial investigated whether pH affects mAb3 storage stability. 
1. Four buffer solutions with various pH values were prepared: 
a. pH 4.5: acetate buffer (10 mM, Biacore BR-1003-50). 
b. pH 7.0: PBS (100 mM). 
c. pH 8.0: tris buffer (50 mM) prepared from a ready-mix sachet. 
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d. pH 9.6: carbonate buffer (50 mM) prepared using the method 
described in Appendix A-1.3. 
2. 1% BSA solutions were prepared with each buffer. The approximate pH of 
each solution was confirmed with pH test paper. 
3. Four aliquots of frozen mAb3 were taken from the freezer. One aliquot was 
thawed and diluted to 202 μg/mL with each buffer. Note: the four thawed 
aliquots were not combined before dilution (only 10 μL was frozen in each 
aliquot). 
4. The solutions were stored in a cold box at about 5°C. 
5. A sub-sample of each stock solution was taken from the cold box and 
diluted to 10 μg/mL using the corresponding buffer containing 1% BSA. 
The solutions were tested by SPR using Test Routine 2. 
6. Step 5 was repeated about 3 h later and 4 d later (solutions were stored in a 
fridge between sampling). 
Initial measurements for samples prepared at different pH values were 
different (Table 15). The response for pH 8.2 (3096.9 RU) was over twice that 
for samples stored at pH 4.5 (1257.4 RU). The pH may affect antibody-antigen 
interaction so more mAb3 binds to the surface at pH 8.2 than at other pH 
values. Even though the SPR running buffer was pH 7.0, most of the sample 
will contact the surface within the sample slug. With hindsight, we should 
have diluted to 10 μg/mL with running buffer to eliminate these differences. 
Alternatively, because aliquots of mAb3 were not combined before being 
diluted in specific buffers, the observed difference could be due to inter-
aliquot differences in activity from frozen storage.  
Compared to previous experience, mAb3 was stable at all pHs. The same batch 
of mAb3 had been used in SPR Surface and Antibody Activity Test III (Section 
4.32) and Syringe Bead Test IX (Section 4.33), yet in those trials the SPR 
response decreased from about 1600 RU to about 10 RU in a few hours. The 
only significant difference between the two experiments (Table 16) is that the 
earlier experiment had no BSA, which may be the critical factor. Some earlier 
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experiments did contain BSA, but only at 0.01% rather than 1%. The lower 
concentration may not prevent degradation, especially if a suboptimal storage 
protocol is used. 
The overall conclusion is that mAb3 is relatively stable over the entire pH 
range (4.5-9.6), but maximum antibody-antigen interaction may occur at about 
pH 8. 
Table 15: Effect of storage pH and time on mAb3 activity. 
Time pH 4.5 pH 7.0 pH 8.2 pH 9.6 
Initial 1257.4 2338.5 3096.9 2548.0 
3 h 1245.7 2050.0 2890.6 2003.9 
4 d 1256.2 1986.1 2827.6 1870.8 
Table 16: Storage conditions for two experiments with differing mAb3 stability. 
Parameter Early experiment 
(Section 4.32 and 4.33; unstable) 
This experiment (stable) 
Antibody 
Ab concentration 
BSA concentration 
Temperature 
Container 
mAb3 
202 μg/mL 
0% 
5°C 
Polypropylene 
mAb3 
202 μg/mL 
1% 
5°C 
Polypropylene 
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Chapter 5 Discussion 
This project had the ambitious objective of developing an assay technology 
platform that could be automated and used as an on-line progesterone 
biosensor. Unfortunately, due to the many problems encountered, a suitable, 
workable procedure was not found. 
The first two major milestones in the project were to coat the beads with a 
progesterone derivative and to conjugate HRP to anti-progesterone. The 
coupling procedures used were not novel. The bead manufacturer provided the 
procedure for coating the beads and a laboratory that had performed exactly 
the same conjugation, and similar conjugations on a regular on-going basis, 
provided the procedure for enzyme-antibody conjugation. Although none of 
the experiments in this study demonstrated conclusively that either coupling 
procedure was successful, some results indicated successful coupling and very 
few were negative. Given enough time, successful coupling would probably 
have been confirmed. 
5.1 Conjugation 
Data from size exclusion chromatography (Section 4.1) and SDS-PAGE 
(Section 4.21) indicate some conjugation. Both these analyses show a 
population of higher molecular weight proteins, which are probably 
conjugated material. This conjugated material has a wide range of molecular 
weights and there is also a significant amount of unconjugated enzyme and 
antibody, casting doubt on the completeness of conjugation. However, the 
presence of unconjugated enzyme and/or antibody should not compromise the 
final assay. Unconjugated enzyme should not bind to the antigen surface, and 
excess antigen on the surface should ensure that unconjugated antibody will 
not inhibit the amount of conjugate that can bind. 
Although the surface plasmon resonance (SPR) response of conjugate and 
unconjugated antibody solution were similar (Section 4.20), this does not 
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indicate whether the antibody binding to the surface has enzyme attached. 
Conclusively demonstrating successful conjugation first requires confirmation 
of an active antigen bead surface. A colour change if first conjugate and then, 
after rinsing, enzyme substrate were exposed to the beads would indicate 
enzyme had bound to the beads. Using uncoated beads, which should not bind 
the conjugate and therefore give no colour change, in a parallel experiment 
would confirm the enzyme causing the colour change is conjugated to the 
antibody. It would be prudent to also demonstrate that free progesterone in 
the conjugate solution inhibits surface binding as this is the practical function 
of the conjugate. 
Experiments to demonstrate these effects (sections 4.4-4.12) were confounded 
by a combination of doubts about activity of the polyclonal antibody for 
progesterone coupled at the 3-carbon, non-specific binding to the beads, and 
the fact that the antigen surface had not been independently confirmed. 
5.2 Bead-Coating 
The Syringe Bead Tests (sections 4.22-4.28, 4.30-4.31; data summarised in 
Table 12) tended to indicate successful coating. The SPR response of antibody 
solutions exposed to coated beads was consistently lower than for solutions 
that had not been exposed to beads or had only been exposed to uncoated 
beads. However, due to problems with antibody stability, the response in these 
control solutions was too low to eliminate doubts that the results were due to 
random fluctuations in SPR response. 
5.3 Antibody Stability 
The key to confirming successful bead coating is to overcome the antibody 
stability issue. Two major problems occurred with antibody during this 
project. Firstly, there were doubts about the binding activity of polyclonal 
antibody (pAb) towards progesterone coupled at the 3-carbon. Lack of activity 
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was never demonstrated in a comparative experiment with proven mAb1. Data 
from both experiments comparing the two antibodies showed similar activity 
(sections 4.14 and 4.15). However, doubts about antibody activity were raised 
in the subsequent experiments (sections 4.16 and 4.17), which used the same 
procedure as in Section 4.15 but without mAb1 as a positive control (at that 
time, pAb was considered the positive control). The pAb may have activity 
towards progesterone coupled at the 3-carbon, but lost it in much the same 
way that mAb1-3 did later in the project. Hindsight suggests that either an 
antibody with a known interaction should have been used, or tests for 
interaction with the antigen should first be done before using the antibody. 
This would have been easy to test using SPR, but by that time, stocks of pAb 
had been exhausted. 
The second issue with antibody was mAb1-3 stability. Antibody was used to 
confirm successful bead coating but it did not retain activity long enough to 
allow conclusive results. Experiments demonstrated that dilution, temperature 
(Section 4.29), pH (Section 4.36), and storage regime (sections 4.32 and 4.33) 
did not affect stability. Data were contradictory; solutions used in the 
dilution/temperature stability trial were stable throughout the day of the 
experiment but had lost all activity the next day (Section 4.30); solutions that 
had been stored under a new regime lost all activity within a few hours; but 
solutions used in the pH trial lasted 4 days without significant loss of activity.  
The latter trial used a BSA concentration of 1% (Section 4.26-4.28) rather than 
no BSA (other stability trials: sections 4.30-4.31) or 0.01% (the latter bead 
tests: Section 4.33). Many modes of protein degradation can be minimised by 
adding a stabilising protein so it is plausible that this could be the key to the 
problem. For example, oxidising agents or degradative enzymes will normally 
attack any protein so adding a large concentration of a dummy protein protects 
the active protein. Likewise, if protein adsorbs to the sides of the container, the 
dummy protein will be adsorbed in proportion to its concentration, thus 
retaining most of the active protein in solution. Adding 0.01% BSA may be 
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insufficient to adequately protect the antibody. Higher concentrations were 
not initially used because of NSB to the SPR surface but this was overcome by 
incorporating longer rinsing times into the SPR test routine (sections 4.34 and 
4.35). An intermediate concentration such as 0.1% would not require such 
long rinsing times but may still provide adequate antibody protection. 
5.4 Non-Specific Binding to Beads 
The polystyrene Tentagel™ Macrobeads tend to enhance NSB. This was best 
demonstrated when antibody exposed to uncoated beads gave a much lower 
SPR response than antibody not exposed to beads (Section 4.24). To test 
whether this had been caused by the syringe, an antibody exposure test should 
be run in an empty syringe. If there is NSB to the syringe, a glass syringe could 
be used. Polystyrene is renowned for NSB. If NSB to the Macrobeads is a 
serious issue, sepharose beads (EAH Sepharose 4B, GE Life Sciences, UK) could 
be used. Sepharose is commonly used in protein purification columns and 
should have minimal NSB. The NSB may be substantially reduced by adding 
higher BSA concentrations in the protein solutions (e.g. 0.1% or 1%). 
5.5 pH of Substrate Reaction 
The substrate reaction can be carried out at pH 7 (Section 4.3), which increases 
the simplicity of an on-line biosensor because the whole assay could be done 
with a single pH 7 running buffer. 
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Chapter 6 Conclusions and Recommendations 
Despite poor progress in this project, there is still optimism. SPR is a fast and 
reliable technique for measuring antibody activity. Using the purpose-built 
coating apparatus to coat only two of the four channels (Section 4.3) will allow 
the non-specific response to be measured on the uncoated channel in real-time 
and subtracted from the response in the coated channel. This would allow 
higher BSA concentrations to be used without compromising activity 
measurements or extending the analysis time. 
Once the antibody stability issue is overcome (which is achievable), it should 
be relatively simple to confirm conjugation and bead coating as both are based 
on well-understood and commonly-used chemistry.  
The next step of proving the assay format is the major hurdle in the project. 
After loading the coated beads into a column, it is necessary to show: (a) 
conjugate is bound to the column as solution passes through; (b) substrate, 
after binding, measurably changes colour; and (c) free progesterone at 
naturally-occurring levels measurably inhibits conjugate binding to the 
column. Because many parameters may affect the assay, these are not simple 
tasks. Once these parameters are set, the economic feasibility of the assay (e.g. 
running cost) will be better understood so a decision on continuing the project 
could be made. 
In summary, many problems were encountered but these did not undermine 
the project’s potential. There is a good chance of success if work were to 
continue. 
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Appendices 
Appendix 1 Recipes for Solutions 
A-1.1 Buffers 
0.2 M sodium phosphate (used 
in the preparation of PBS) 
27.8 g NaH2PO4.H2O 
Up to 1000 mL with distilled water 
0.2 M sodium biphosphate 
(used in the preparation of 
PBS) 
28.4 g Na2HPO4
Up to 1000 mL with distilled water 
0.1 M Phosphate Buffered 
Saline (pH 7.0) (PBS) 
195 mL 0.2 M sodium phosphate 
305 mL 0.2 M sodium biphosphate 
8.7 g NaCl 
Dilute to approx. 950 mL with distilled water 
pH to 7.0 with 5 M HCl or 5 M NaOH 
Store at 4°C 
0.05 M carbonate buffer (pH 
9.6) 
1.59 g Na2CO3
2.93 g NaHCO3
Dissolve in approx. 950 mL distilled water 
pH to 9.6 with 5 M HCl or 5 M NaOH 
Up to 1000 mL with distilled water 
Store at 4°C 
Phosphate/citrate buffer (pH 
5.0) 
4.668 g anhydrous citric acid 
7.309 g Na2HPO4
Dissolve in approx. 950 mL distilled water 
pH to 5.0 with 5 M HCl or 5 M NaOH 
Up to 1000 mL with distilled water 
A-1.2 Enzyme Substrate Solutions 
0.2 mg/mL 
tetramethylbenzidine 
dihydrochloride (TMB) 
solution 
10-11 mg TMB 
12.5 mL methanol 
Up to 50 mL with distilled water 
3% hydrogen peroxide solution 100 μL 30% H2O2
900 μL distilled water 
Prepare immediately before use 
TMB solution 5 mL phosphate citrate buffer (pH 5.0) 
5 mL 0.2 mg/mL TMB solution 
20 μL 3% hydrogen peroxide solution 
Prepare immediately before use 
Colour develops with absorbance at 630 nm 
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A-1.3 Regenerants 
Regenerant 1 5 M NaOH 
Regenerant 2 20 g 5 M NaOH 
20 g NaCl (2% w/w) 
Up to 1000 g with water 
pH 12.5 
Regenerate 3 2 g 5 M NaOH  
100 g Acetonitrile 
10 g 10% sodium benzoate 
Up to 1000 g with water 
A-1.4 Progesterone Standard Solutions 
Progesterone stock standard 
solution (10 μg/mL) 
On a 5 d.p. balance (0.01 mg resolution) weigh out 
1.00 g progesterone 
Make up to 100 mL with absolute ethanol 
Taking care to minimise evaporation of ethanol (eg 
Use a syringe), transfer the standard to 2 mL glass 
vials (approx. 2/3 full) 
Store in freezer 
Progesterone secondary 
standard solution (400 ng/mL) 
Pipette 1 mL 10 μg/mL stock standard into 25 mL 
volumetric flask 
Blow down ethanol standard to dryness 
Make up to 25 mL with PBS 
Store in 0.5 mL aliquots in glass vials in freezer 
A-1.5 SDS-PAGE solutions 
These solutions were kindly provided by AgResearch, Ruakura, Hamilton 
5X Sample loading buffer 
(reducing) 
2.5 mL 0.5 M Tris buffer (pH 6.8) 
8 mL glycerol 
1 g SDS 
5 mL H2O (MQ) 
5 mL B mercaptoethanol 
Some grains of bromophenol (to colour dark blue) 
Aliquot 1 mL, store -80°C 
Coomassie Stain 1L 0.2 g Coomassie R250 
100 mL acetic acid (glacial) 
300 mL methanol (drum) 
600 mL water 
Coomassie Destain 1L 100 mL acetic acid (glacial) 
300 mL methanol (drum) 
600 mL water 
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A-1.6 Other Solutions 
ELISA plate wash-solution Stock solution: 
87.66 g NaCl 
5.0 mL Tween 20 
Up to 1000 mL with distilled water 
Add 100 mL stock solution to 900 mL distilled water 
P4-HRP stock solution (1:200) 0.250 mL conjugate stock 
Up to 50 mL with PBS with 1% BSA 
Store in 1 mL aliquots in glass vials freezer 
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Appendix 2 Suppliers 
 
Item Manufacturer Supplier Product No. 
Acetonitrile 
Albumin, bovine serum 
Antibody, polyclonal (pAb) 
Antibody, monoclonal (mAbX) 
Beads, 300 μm Tentagel Macrobeads™ (-NH2) 
Beads, 90 μm (-NH2) EAH Sepharose 4B 
Biacore Amine Coupling Kit 
Biacore CM5 chip 
Buffer, acetate pH 4.5 
Buffer, HBS-EP pH 7.4 
Citric acid 
Dimethylformamide 
Ethanol, 100% 
Ethylene diamine 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
N-hydroxy succinimide 
Horseradish peroxidase 
Hydrochloric acid, 5M 
Hydrogen peroxide 
Methanol 
Merck 
ICP Bio 
Sigma-Aldrich 
UC Davis 
Rapp Polymere 
GE Life Sciences 
Biacore 
Biacore 
Biacore 
Biacore 
BDH 
BDH 
- 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Pauling Industries 
BDH 
BDH 
Biolab, Auckland, NZ 
ICP Bio, Auckland, NZ 
Biolab, Auckland, NZ 
UC Davis, USA 
Rapp Polymere, Germany 
GE Life Sciences, UK 
Bio-Strategy, Auckland, NZ 
Bio-Strategy, Auckland, NZ 
Bio-Strategy, Auckland, NZ 
Bio-Strategy, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
InterAg, Hamilton, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Pauling Industries, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
1.00030 
ABRE-001 
P5289 
CL425 (9/8/00) 
MB 300 02 
17-0569-01 
BR-1000-50 
BR-1003-99 
BR-1003-50 
BR-1001-88 
277814N 
103224J 
- 
E26266 
E7750 
130672 
P8375 
HCl 5.0N 
103665H 
10158BG 
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Item Manufacturer Supplier Product No. 
Progesterone 
Progesterone-3-carboxymethyloxime 
Progesterone-horseradish peroxidase 
Plate reader (Multiskan EX) 
Plate reader, optical filter 630 nm 
Sodium benzoate 
Sodium bicarbonate 
Sodium biphosphate 
Sodium borohydride 
Sodium carbonate 
Sodium chloride 
Sodium phosphate 
Sodium hydroxide 
Sodium periodate 
Tetramethylbenzidine (powder) 
Tetramethylbenzidine (formulation) 
Tween 
Sigma-Aldrich 
Sigma-Aldrich 
UC Davis 
Thermo 
Thermo 
BDH 
Merck 
Scharlau 
Ajax Finechem 
Merck 
Labserv (Biolab) 
BDH 
BDH 
Ajax Finechem 
Sigma-Aldrich 
Sigma-Aldrich 
APS Chemicals 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
UC Davis, USA 
Medica Pacifica, Auckland, NZ 
Medica Pacifica, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
Biolab, Auckland, NZ 
P8783 
P3277 
- 
51118170  
1426300 
103974R 
1.06329 
So 0337 
A2334 
1.06392 
BSPSL944 
102454R 
102524X 
A695 
T8768 
T0440 
2509 
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